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Programmed cell death (PCD) is an important process in the development of
multicellular organisms. Apoptosis, a form of PCD characterized morphologically by
chromatin condensation, membrane blebbing, and cytoplasm compaction, and
molecularly by the activation of caspase proteases, has been extensively investigated.
Studies in C. elegans , Drosophila , mice, and the developing chick have revealed,
however, that developmental PCD also occurs through other mechanisms,
morphologically and molecularly distinct from apoptosis. One prominent cell death
program, linker cell-type death (LCD), is morphologically conserved, and independent of
the key genes that drive apoptosis. Instead, LCD functions, in part, through the stressrelated protein HSF-1, and subsequent upregulation of members of the ubiquitin
proteasome system. How exactly HSF-1 is post-translationally regulated to either
commit to cell survival or cell death is not currently known. Using a protein interaction
screen and classical genetic studies, I propose that the homeodomain protein kinase
HPK-1 is required to activate the heat shock function of HSF-1, thereby indirectly
inhibiting its cell death role. I hypothesize that PQN-41C, a polyglutamine protein

necessary for linker cell death, binds HPK-1 to limit its HSF-1 interactions, and pushes
the cell towards death.
Downstream of cell death, the linker cell must be phagocytosed and degraded by
engulfing cells. This process does not rely on canonical apoptotic factors, so I carried
out a forward genetic screen to identify genes involved in corpse degradation. I
discovered a key protein network involved in linker cell corpse engulfment and
degradation and revealed that two small GTPases, RAB-35 and ARF-6, and their
regulators ensure timely phagocytosis and phagosome maturation. I also determined
that the caspase CED-3 and its upstream regulator CED-4 are required not for cell
death, but for proper cell corpse removal. This new role of caspase in cell corpse
disposal offers an alternative function for the role of caspases in cell death, and
suggests how apoptotic and non-apoptotic forms of cell death may work together to
remove cells during animal development.

To Luka and Elias:

“Think and wonder,
wonder and think.”
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1. Introduction
1.1. Programmed cell death
The term Programmed Cell Death (PCD) was first coined to describe cell
elimination that occurs at precise locations and times during development [1], although
cell death as a phenomenon had been described as early as the 1885 [2]. This process
is key for sculpting tissues and organs, for removing excess or unnecessary cells,
and for tissue homeostasis. The reproducible and consistent patterns of cell death in
developing animals led to the idea that specific genes are driving the phenomenon.
Indeed, genes promoting apoptosis, a form of PCD characterized by chromatin
condensation, membrane blebbing, and cytoplasm compaction [3,4] (Figure 1-1),
were initially isolated in Caenorhabditis elegans [5]. The discovery that the C. elegans
caspase gene ced-3 is required for developmental apoptosis, and the subsequent
realization that caspase homologs in Drosophila and in vertebrates also promote
apoptosis, demonstrated that underlying the stereotypical morphological signature
is a conserved molecular program [6,7]. In species as diverged as C. elegans and
the mouse, apoptosis is mediated by caspase proteases, activated by a conserved
scaffolding protein called CED-4 in C. elegans and APAF1 in mice. Bcl-2 family proteins
act upstream of CED-4/APAF1 to control its activation. This occurs by direct binding in
C. elegans [8], or through release of mitochondrial cytochrome C, which oligomerizes
APAF1 in mammals [9].
1.2. A brief introduction to developmental apoptosis in C. elegans and
Drosophila
In C. elegans, a BH3-only-like protein, EGL-1, inhibits CED-9, a Bcl-2like protein [10] (Figure 1-2a). This removes the inhibition that CED-9 places on
CED-4, an APAF1 homolog [11]. Activated CED-4 cleaves CED-3, a caspase, into

1

Figure 1-1. Morphology of an apoptotic corpse.
In apoptosis, chromatin is highly condensed and darkly
staining, but the nuclear envelope remains round
(C. elegans cell, courtesy of Yun Lu).
its functional form [5]. Later, molecular apoptosis was confirmed and expanded in
Drosophila melanogaster and in mouse [12,13].
In Drosophila, apoptotic stimuli gather Inhibitor of Apoptosis Proteins (IAP)
antagonists, including Reaper, Hid, Grim, to the mitochondria, to inhibit the IAP,
Diap1 [13-16]. IAPs were found to negatively inhibit caspases in Drosophila and other
organisms [17,18] (Figure 1-2b). Inhibition of IAPs allows for the APAF1-like protein Ark
to activate the Caspase-9-like protein Dronc [19-21]. Downstream of Dronc, caspases
DrICE and Dcp1 promote apoptosis [22,23].
1.3. A brief introduction to developmental apoptosis in mammals and
evidence of alternative cell death pathways
In mammals, the core components of the apoptosis pathway combine aspects of
the pathways from worms and flies, with molecular paradigms upstream of mitochondria
similar to C. elegans, and those downstream of the mitochondria similar to Drosophila
(Figure 1-2c). For example, BH3-only proteins inhibit Bcl-2 family members upon
activation by an apoptotic stimulus [24], similar to C. elegans. This lifts the negative
inhibition that Bcl-2 family members place on Bax and Bak at the mitochondria [25],
allowing these proteins to form pores on the outer mitochondrial membrane and
release cytochrome C [26,27]. Blocking Bax and Bak is thought to inhibit all forms of
intrinsic apoptosis [28]. Additionally, this also releases IAP-binding partners to promote
apoptosis [29,30], similar to Drosophila. Cytochrome C release leads to the activation
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of the apoptosome containing multimeric APAF1, which activates the initiator caspase,
caspase-9; this in turn activates the executioner caspases, caspases -3 and -7 [30,31].
Although initial reports of mice harboring knockout mutations in caspase genes,
in Apaf1, or in both Bax and Bak suggested that these genes play important roles in
vertebrate developmental cell death [13,32-36], breeding mutants onto different genetic
backgrounds revealed that homozygous knockout mice were not only born, but could
survive to adulthood, often exhibiting only minor defects [36-39]. For example, while
initial reports suggested that mice defective in Apaf1 exhibit inappropriate webbing
between the digits of the pentadactyl limb, later analysis revealed only a delay in
the process, with complete culling of the webbing within two days [34,35]. Mutations
in Caspase-3 or Caspase-9 do not affect this process [33,40]. Furthermore, while
persistence of small webs are observed in Bax; Bak double mutants, this surviving
tissue is a small fraction of what survives in Bmp mutants, in which cell death is
indirectly blocked [41,42].
Similarly, early studies of Caspase-3 mutants revealed mice with apparent skull
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apoptosis protein (IAP) antagonists Reaper, Head involution defective (Hid) and Grim (which are known as the RHG
proteins) mediate the degradation of Death-associated IAP 1 (Diap1), thereby liberating the executioner caspases Ice and
Death caspase 1 (Dcp1). In addition, this enables Death regulator Nedd2-like caspase (Dronc), which is a caspase 9
homologue, to interact with Ark (an APAF1 homologue) and form the apoptosome that efficiently activates the executioner
caspases. The protein p35 is a specific inhibitor of executioner3caspases, and the activation of the apoptosome may be
regulated by the BCL-2 family members Debcl and Buffy (hence depicted by a dashed line and question mark).
c | In mammals, the crucial decision as to whether a cell commits to apoptosis is regulated by an interplay between the

fractures and protruding brain tissue, suggesting a vast excess of neurons in the brain,
consistent with the observation that in some brain regions up to 80% of cells that are
originally produced are thought to undergo PCD [13,43]. Subsequent examination,
however, revealed no increase in neuronal cell number [44]. Rather, defects in the
sutures that bind skull bones together appear to be the cause of skull disruption [45],
and oozing of brain tissue is likely a consequence of the release of intracranial pressure
to which the brain is normally subjected.
Although the absence of massive cell survival in Caspase-3 or Caspase-9
mutants could be explained by redundant activities of these enzymes, as the mouse
harbors 13 caspase genes [46], only a single Apaf1 gene is found in the murine genome
[34]. Furthermore, studies of Bax; Bak double mutants suggest that developmental
apoptosis is nearly entirely abrogated, yet some animals still develop normally to
adulthood [36]. Thus, an alternative explanation may be the existence of caspaseindependent non-apoptotic processes. Cells dying with non-apoptotic features during
animal development have been extensively described [47], yet little is known about
the underlying molecular effectors of these alternative death programs, or their in vivo
relevance.
1.4. Non-apoptotic developmental cell death
While most developmental cell death in Drosophila and C. elegans proceeds via
apoptosis, these organisms also provide highly amenable settings for non-apoptotic
pathway discoveries.
1.4.1. Germ cell death in Drosophila males
Pre-meiotic male germ cells undergo stochastic PCD in the adult fly testes, and
dying cells display some apoptotic features, including cytoplasmic compaction and
chromatin condensation [48] (Figure 1-3a). Dying germ cells are also TUNEL-positive,
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Figure 1-3. Germ cell death in Drosophila males.
(a) In adult males, germ cell death occurs within the testes (green). (b) Dronc, a
Caspase-9-like protease, functions in an apoptosome-independent fashion to perhaps
trigger lysosome membrane permeabilization (LMP), allowing the release of the
protease CathepsinD and the nuclease DNaseII. At the mitochondria, Bcl-2 family
members Debcl and Buffy function on the outer membrane, and the Parkinson-related
protein Pink1 functions within. ROS may trigger release of the serine protease HtrA2/
Omi and the nuclease EndoG [48].
suggesting chromosomal DNA fragmentation. Surprisingly, these wild-type cells are
not stained with an antibody against cleaved Caspase-3, which binds the executioner
caspases Drice and Dcp-1 [48]. Furthermore, cells still die when these caspases are
knocked down, suggesting that germ cell death is non-apoptotic. Correspondingly,
unlike apoptotic cells, mitochondria of dying wild-type germ cells appear deformed and
swollen [48].
Although germ cell death does not employ executioner caspases, it does require
an APAF1-independent function of the initiator caspase Dronc [48]. Mutations in the
Apaf1 homolog, ark, in fact, increase cell death, perhaps because more Dronc is now
available to induce non-apoptotic death [48,49]. Mutations in dronc result in a 40%-60%
decrease in death. This defect is specific, as lesions in the initiator caspases strica
and dredd have no effect. The mechanism of Dronc action here is not fully understood.
However, lysosomal biogenesis proteins and the lysosomal protease cathepsinD are
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required for efficient demise, and an increase in reactive oxygen species (ROS), and
acidification of the cytoplasm occur [48]. ROS and Dronc may promote lysosome
membrane permeabilization, allowing release of cathepsinD and DNaseII into the
cytosol [48] (Figure 1-3b). The release of DNaseII may explain TUNEL staining in the
absence of cleaved Caspase-3.
Yacobi-Sharon and colleagues discovered that the mitochondrial protease HtrA2/
Omi plays an important role in germ cell death [48]. Drosophila carrying deletions of
either one or both htrA2/omi copies are viable, but exhibit male sterility associated with
a decrease in germ cell death. htrA2/omi encodes a multi-domain protein containing
a mitochondrial targeting sequence, an IAP-binding motif (IBM), a serine protease
domain, and a protein-interaction domain. Structure-function analysis revealed that
the catalytic domain, but not the IBM, is crucial for death [48]. Remarkably, htrA2/omi
lesions in humans are associated with Parkinson’s disease [48], and mutations in the
Parkinson’s disease- and mitochondrial-associated gene pink1 also cause a decrease
in Drosophila germ cell death. Overexpression of a cytosolic version of HtrA2/Omi
promotes caspase-independent cell death in mammalian cells [51], accompanied by
morphological similarities to Drosophila germ-cell death, although nuclear changes
are not evident [48,51]. Roles for mitochondria in Drosophila germ cell death are
also supported by the findings that the Bcl-2 family proteins Debcl and Buffy, and the
mitochondrial nuclease EndoG, promote death [48] (Figure 1-3b).
Additionally, GCD does not function completely independent of caspases, but it
provides a good model for how both caspase-dependent and independent mechanisms
can work together to kill cells. Aspects of GCD may be conserved in some mammalian
necrotic pathways. For example, in immortalized mouse embryonic fibroblasts (MEFs),
introduction of tumor necrosis factor (TNF) can induce a non-apoptotic cell death
program that does not utilize executioner caspases [52]. Instead, like GCD, lysosomes
and caspase-9, but not APAF1, are required [52]. The upstream signaling and some

6

molecular components of TNF-induced cell death differ from GCD, but the similarities
are striking nonetheless. In addition, LMP, like that observed in GCD, is important for
mammary gland epithelial cell death after weaning [53].
In rodents, male germ cells also undergo stochastic cell death that may be
caspase independent [54,55]. Mutations in the pro-apoptotic gene Bax do not block
these deaths, suggesting possible involvement of non-apoptotic programs [56,57].
Furthermore, mutations in the testes-specific serine protease inhibitor spink2 result in
increased germ cell death in male mice [55]. These observations provide circumstantial
evidence that conserved pathways may control stochastic germ cell death in males
across species.
1.4.2. Nurse cell death in Drosophila females
In the Drosophila ovary, 15 nurse cells provide a developing oocyte with proteins,
mRNA, and organelles [58] (Figure 1-4a). After extruding their cytoplasmic contents
into the oocyte, nurse-cell remnants die. Dying wild-type cells exhibit chromatin
condensation, but also autophagosomes, ruptured lysosomes, and larger vacuolar
structures [59,60]. Dying cells stain with acidification markers, autophagic markers, and
TUNEL [59-62], raising the possibility that more than one cell death program is involved.
Whether caspases promote nurse cell death is debated. Some studies report no
activated caspases in dying cells [63,64], whereas others report immunoreactivity using
an activated Caspase-3 antibody [61,62]. Mutants in Drosophila inducers of apoptosis
(hid, reaper, grim) do not exhibit nurse cell survival, suggesting a caspase-independent
process [65,66], and some studies suggest that overexpression of the caspase
inhibitors diap1 or p35 also does not perturb nurse cell death [62,63]. However, other
studies suggest that such overexpression weakly blocks death [67].
Genetic studies demonstrate that nurse cell death still proceeds in dronc, dredd,
strica, dcp-1, or drice caspase single mutants [23,67,68]. However, dredd; strica or

7

a

b

Dying nurse cell
LMP?

Nurse cell
death
within ovaries

Lysosomal
fusion
Nuclease

Draper Engulfment
Ced-12

genes

Spinster
DNaseII

Surrounding
follicle cell

Nurse Cell Death
and Degradation

Figure 1-4. Nurse cell death in Drosophila females.

(a) In the female adult fly, nurse cell death occurs within the ovaries (purple). (b) The
surrounding follicle cells may induce nurse cell death, using the engulfment receptors
Draper and Ced-12 via phagoptosis. Downstream events may lead to lysosome
membrane permeabilization (LMP) and the release of the lysosomal fusion protein
Spinster and the nuclease DNaseII. Caspases and autophagy may be minimally
involved.
dcp-1; drice double mutants exhibit weak survival, suggesting that caspases may be
relevant, but functionally redundant [67]. Congruently, mutants in Apaf1/ark, which
functions upstream of initiator caspases, also exhibit weak nurse cell death defects [66].
In developing nurse cells in vitro, the Caspase-3-inhibitor Z-DEVD-FMK blocks
DNA fragmentation but not chromatin condensation [69]. While mutations in inhibitor
of caspase-activated DNase (ICAD) cause a decrease in cleaved DNA, as assessed
by a PCR assay, nurse cells still clear their DNA efficiently [70]. In another study,
however, mutants in dICAD displayed weak nuclear persistence, similar to Apaf1/ark
mutants [66]. Together, these data suggest that caspases may play some role in nurse
cell death.
The role of autophagy in nurse cell death is also unclear. Despite the presence
of autophagosomes, autophagy-related protein levels are not increased in dying
cells [60,63]. However, one study reported that nurse cell nuclei persist in mutants of
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the autophagy genes atg1 and atg13 [61]. This defect, however, is not fully penetrant,
suggesting other processes are probably involved [61]. atg7; dcp-1 double mutants
exhibit similar defects to atg7 single mutants [71], indicating that these other pathways
may be caspase independent.
Lysosomes may play important roles in nurse cell death and removal
(Figure 1-4b). Mutants in the lysosomal nuclease DNaseII and the lysosomal trafficking
protein deep orange/Vps18 exhibit persisting nurse cell nuclei [60,71], as do mutants
in the lysosomal fusion protein Spinster and the lysosomal protease CathepsinD [60].
While Deep Orange is required in the engulfing follicle cells, DNaseII and Spinster
appear to function cell autonomously [60]. Thus, lysosomes may have multiple activities
in nurse cell death, although these results are complicated by the fact that some of
these mutants perturb cytoplasm transfer to the oocyte, which may delay or impede
death [59].
Recent research raises the possibility that the primary nurse-cell-death
mechanism may be phagoptosis (primary phagocytosis), such that death of nurse cells
is non-autonomously promoted by surrounding follicle cells [72]. Consistently, mutants
in the engulfment genes draper and ced-12 display nurse cell survival, and Draper is
required for nurse cell acidification [72]. Furthermore, ablation of surrounding follicle
cells strongly inhibits nurse cell death, although cytoplasm transfer is also blocked,
complicating interpretation of the persistent nuclei phenotype [72]. However, it is
possible that nurse cell death may be an example of assisted suicide.
1.4.3. Salivary gland cell death in Drosophila larvae
Drosophila salivary glands are larva-specific structures that are rapidly degraded
after puparium formation [73,74] (Figure 1-5a). Dying wild-type cells exhibit apoptotic
features, but also an abundance of autophagosomes, and nuclear separation from
the cytoplasm [75,76]. Both autophagy and caspase genes are induced during
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Figure 1-5. Salivary gland cell death in Drosophila larvae.
(a) After puparium formation, large larval salivary glands (blue) die and degrade before
the adult fly hatches. (b) The engulfment gene Draper is required cell-autonomously
within the salivary glands to drive cell death, and may lead to downstream activation of
autophagy genes like Atg18. Caspases may work in parallel.
salivary gland cell death [77,78], although the precise contribution of each is not fully
understood. Caspases may be dispensable for cell death. Loss-of-function mutants
in dronc or drice caspase genes or in Apaf1/ark do not strongly perturb salivary gland
death and degradation [74,79]. While expression of the caspase inhibitor p35 halts DNA
fragmentation and nuclear lamin cleavage [75,76], it does not result in intact cells [78].
Instead, fragments appear to persist inappropriately [74], suggesting a cell degradation
role for caspases.
Autophagy is induced prior to salivary gland cell death, and in the absence of the
autophagy-related gene atg18, salivary glands are not properly degraded, exhibiting
vacuolated cell fragments [74] (Figure 1-5b). These findings provide in vivo evidence
for a role of autophagy in degrading dying cells [74]. Combining autophagy and
caspase inhibition blocks gland degradation further, but not cell death, suggesting these
pathways function in parallel [74]. Cell death can be inhibited by overexpression of the
PI3K active subunit Dp110 and p35, suggesting involvement of a PI3K target [74].
The salivary glands are large structures, and their phagocytosis by neighboring
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cells is not well understood. The engulfment gene draper is required to induce
autophagy cell-autonomously in the salivary gland cells, and not for engulfment [76,80],
suggesting an unexpected and intimate connection between engulfment and
degradation genes. Such a connection had been described for nurse cell death (see
above) [72]. In C. elegans, engulfment genes also appear important in some contexts
for promoting nuclease activation for cell degradation [81].
1.4.4. Linker cell death in C. elegans
The C. elegans male-specific linker cell leads gonad elongation. During the L4
larva-to-adult transition, the cell dies, allowing gonad-cloaca fusion for sperm release
and male fertility (Figure 1-6a). The dying linker cell is engulfed by its neighboring
U.l/rp cells [82]. Morphologically, wild-type linker cell death is non-apoptotic: chromatin
is not condensed, the nuclear envelope becomes crenellated, and mitochondria and
endoplasmic reticulum swell [82] (Figure 1-7). Death proceeds even when all four
C. elegans caspase genes are inactivated, and mutations in other core apoptotic genes
also fail to prevent death [82,83]. Thus, linker cell death represents the first example
of a non-apoptotic caspase-independent cell death process required for development.
The morphology of dying linker cells is frequently seen in vertebrate development, and
we have termed this appearance linker cell-type death (LCD). Importantly, although
invaginated membranes are often artifacts of EM fixation, this is not the case for linker
cell nuclear crenellation, as this feature is detected in the living animal under light
microscopy. In vertebrate settings, LCD ultrastructural features are distinguished from
EM artifacts or natural variability as they are seen only at specific developmental times,
and accompany only populations of dying cells and not their neighbors (see below).
Work in the lab revealed multiple control pathways promoting linker cell death.
This death must be tightly regulated, as premature demise blocks gonad elongation,
resulting in sterility [84]. Two opposing Wnt pathways control death onset (Figure 1-6b).
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Figure 1-6. The linker cell dies independent of caspases.
(a) The linker cell (green) is a male-specific cell that leads the elongation of the
developing gonad. Once it reaches its destination, it dies, and is engulfed by the U.l/
rp cells (purple), allowing fusion of the gonad with the cloaca. (b) Multiple regulatory
pathways are required to ensure the linker cell dies at the proper place and time. These
pathways include two antagonistic Wnt pathways (blue), the developmental timing
protein LIN-29 (red), Sarm/TIR-1, the MAPKK SEK-1, and the polyglutamine protein
PQN-41 (green), and the nuclear hormone receptor NHR-67 (purple). These pathways
converge on the heat shock factor HSF-1, which acts in parallel with the SET-16 histone
methyltransferase complex (orange). The pro-death function of HSF-1 competes with
its pro-survival function. HSF-1 may transcriptionally upregulate the E2 ubiquitinconjugating enzyme LET-70 (purple). The transfer of ubiquitin from the E1 UBA-1,
through LET-70, to an E3 complex may confer substrate specificity leading, perhaps to
degradation of key proteins by the proteasome, resulting in linker cell death.
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Frizzled and MOM-5/Frizzled, acting within the linker cell with MIG-5/Disheveled and
BAR-1/β-catenin, which promotes death [85]. Two transcription factors, NOB-1/Hox and
the EOR-1/-2/PLZF complex, likely control the EGL-20/Wnt pathway [86].
In parallel, TIR-1, the C. elegans ortholog of the human Sarm protein, activates
the MAPKK protein SEK-1 to promote linker cell death [87]. SEK-1 may promote
expression of the polyglutamine-repeat protein PQN-41. PQN-41 expression is induced
in the linker cell at the onset of death, and a GFP-tagged version forms puncta within
the linker cell [87]. How exactly PQN-41 promotes cell death is currently unknown.
The zinc finger protein LIN-29, a component of a developmental timing
program [88], also promotes death, as does the nuclear hormone receptor NHR-67 [86].
These genes appear to act independently of and in parallel to the Wnt and MAPKK
pathways [86], and ensure that the linker cell is dying in the correct place at the right
time.
Linker cell death can be restored to mutants carrying lesions in the upstream
control pathways by a gain-of-function mutation in HSF-1, a highly conserved
transcriptional regulator of the heat-shock and other stress responses. HSF-1 loss14

of-function blocks linker cell death. Thus, HSF-1 likely functions downstream of or in
parallel to the regulators described above [85]. A pro-death role for HSF-1 is surprising,
as HSF-1 is typically responsible for promoting survival in response to stress. In animals
exposed to a heat shock 4h before death onset, the linker cell survives inappropriately,
suggesting that the pro-death and pro-survival functions of HSF-1 may compete [85].
We hypothesize that HSF-1 is post-translationally modified, and these modifications
promote either the cell survival or cell death role, depending on context. Which genes
are responsible for these modifications in LCD is currently unknown, however.
Genetically, HSF-1 functions at the same step as the SET-16 H3K4 histone
methyltransferase complex, similar to the mammalian MLL3/4 complex. C. elegans
complex components include SET-16, SWD-2.2, UTX-1, ASH-2, RBBP-5, WDR-5, and
PIS-1, and mutations or RNAi against any of these components promotes inappropriate
survival [86].
Genetic, expression, and functional studies suggest that HSF-1 may work by
transcriptionally activating components of the ubiquitin proteasome system [85]. The
single C. elegans E1 enzyme, UBA-1, is required for cell death through activity of
the E2 ubiquitin-conjugating enzyme LET-70, homologous to mammalian UBE2D2.
LET-70/UBE2D2 appears to act through an E3 ubiquitin ligase complex comprising the
cullin CUL-3, the ring box protein RBX-1, the BTB domain containing protein BTBD-2,
and perhaps SIAH-1 [85]. The identities of substrates binding to this E3 complex are
unknown, but may provide critical clues to how this caspase-independent cell death is
executed. It is possible, for example, that degradation of a critical substrate through this
E3 complex is the key to the lethal effects of the pathway. Correspondingly, proteasome
19S regulatory domain components are required for linker cell death [85].
Molecular components related to those promoting linker cell death have been
implicated in degeneration and death in other settings. Wallerian degeneration is
a process by which the distal process of an injured neuronal axon degenerates,
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leaving the cell body intact. Wallerian degeneration slow (WldS) mice have persistent
axotomized axons [89] caused by an abnormal protein fusion between an NAD+
synthesis protein, NMNAT, and the ubiquitin factor E4B (Ube4b) [90]. Recent work has
revealed that mutations in dSarm, the Drosophila homolog of C. elegans tir-1 required
for linker cell death, also suppress Wallerian degeneration in the fly [91]. Likewise,
murine Sarm promotes Wallerian degeneration in vivo [91]. Overexpression of the SAMTIR domains of murine Sarm in cell culture promotes death that appears non-apoptotic,
as it proceeds in the presence of caspase inhibitors [92].
In wild-type mice, injury to cortical and dorsal root ganglion (DRG) neurons
causes degeneration of the axotomized axon [91]. In Sarm1-/- neurons, however, the
axons persist over an 18h period. In vivo, axotomy at the sciatic nerve in wild-type
animals causes the axons to degenerate and a disintegration of the integrity of the
neuromuscular junctions (NMJ). In Sarm1-/- animals, the axons persist and remain
innervated to the NMJs. When the SAM-TIR domains of Sarm1 are overexpressed
(Sarm1 lacking first 408 amino acids) in DRG cells in culture, the cells die in a nonapoptotic manner [92]. Pro-apoptotic factors, caspase inhibitors, calpain inhibitors, or
extracellular calcium chelation do not inhibit this SAM-TIR-induced cell death [92]. In
primary DRG, mitochondrial depolarization by the protonophore molecule CCCP results
in axon degeneration and cell death [93]. This induced cell death is non-apoptotic, but
requires Sarm1 to degenerate and kill the cells, even in the presence of mitochrondrial
depolarization. The authors designate this cell death as sarmoptosis [93]. It remains
unclear, however, if this cell death occurs in normal mammalian development, and how
different it is from LCD.
In the linker cell, TIR-1/Sarm1 regulates expression of the polyQ repeat protein,
PQN-41 [87]. While PQN-41 function is not well understood, its sequence raises the
hypothesis that polyQ-expansion neurodegenerative diseases, such as Huntington’s
disease, may be instances of a developmental program gone awry [94]. Supporting
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this, in a mouse Huntington’s disease model, dying cells exhibit swollen mitochondria
and golgi, and crenellated nuclei, strikingly reminiscent of linker cell death [95]
(Figure 1-8a,b). TUNEL staining is not detected in dying neurons [96]. Crenellated
nuclei are also found in dying cells of other polyQ disease models and in human
patients [97-102] (Figure 1-8c-e).
Intersegmental muscles (ISMs) of the moth, Manduca sexta may also prove
fertile ground for exploring similarities with linker cell death. Wild-type ISM cells that
die during metamorphosis exhibit non-apoptotic features: chromatin condensation is
not seen, nor are DNA fragmentation, or membrane blebbing [103]. However, ubiquitin
expression is induced, similar to linker cell death [104]. Furthermore, an E1 ubiquitinactivating enzyme, several E2 ubiquitin-conjugating enzymes, and E3 ubiquitin ligases
are induced [105]. Molecular characterization of these proteins and their targets may
expose similarities to linker cell death.
1.5. Non-apoptotic cell death in mammalian development
Although non-apoptotic cell death pathways have been described in vertebrate
cells, including necroptosis, ferroptosis, or pyroptosis, none appear to be required for
normal development, as elimination of key genes regulating these processes does
not affect development or developmental cell death [106,107]. Nonetheless, evidence
that non-apoptotic cell death has important roles in vertebrate development abounds,
including but not limited to, the formation of the mammalian palate [108] (Figure 1-8f),
cornification of epidermal keratinocytes [109], and lysosome-mediated mammary gland
involution after lactation [53]. In the following subsections, I highlight four additional
salient examples that raise the possibility that non-apoptotic cell death programs may
indeed be the norm during vertebrate development. Whether such programs back up,
act in parallel, or function independently of apoptosis is not easy to distinguish, as a
key test for their non-apoptotic nature is whether they proceed without apoptotic genes-
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Figure 1-8. Crenellated nuclei (pseudocolored yellow, red arrows) are prevalent in
disease models and in normal development.
(a) In a mouse model of Huntington’s disease, crenellated nuclei are prominent in
almost all the cells of the striatum [95]. Black arrow, neuronal nuclear inclusion. (b)
They are also prevalent in dark neurons of a mouse model of Huntington’s disease [96].
(c) In brain autopsy samples of a Huntington’s disease patient, crenellated nuclei with
uncondensed chromatin are present [102]. (d) In a cell line overexpressing a pathogenic
Ataxin-3, crenellated nuclei were apparent prior to non-apoptotic cell death [99]. (e) In
the CAG repeat disease dentatorubral-pallidoluysian atrophy, autopsy samples from
patients have nuclear membrane indentations in some granule cells in the cerebellar
cortex [100]. Star, intranuclear inclusion. (f) Dying cells from the developing palatal
shelf display crenellated nuclei [108]. (g) While Caspase-9 null ESCs rarely die after
UV treatment, those that do display LCD features, including open chromatin, swollen
organelles, and crenellated nuclear envelope [32]. Ch, chromatin. (h) Degenerating
motoneurons in Bak knockout mice have crenellated nuclei, and are small and
atrophied [112]. N, nucleus. m, mitochondria. rer, rough endoplasmic reticulum. Black
arrow, synapse. Dotted line, soma. (i) Degenerating motoneurons in a wild-type stage
24 chick spinal cord have indented nuclei [115]. (j) Non-apoptotic dying retinal ganglion
cells in the same organism have crenellated nuclei after axotomy [117]. (k) Peripherally
deprived ciliary ganglion neurons in the embryonic chick display highly indented nuclei
[118]. N, nucleus. (l) Avian motoneurons in culture adopt either an apoptotic morphology,
or an LCD morphology as shown here, with highly crenellated nuclei, and swollen
organelles at later timepoints (not shown) [119]. Scale bar = 1 μm. (m) In the presence
of caspase inhibitors, motoneurons in the chick acquire non-apoptotic morphology [120].
n, nucleus. (n) Mouse uterine epithelial cells die shortly after implantation, and these
cells display irregularly shaped nuclei [125]. (o) Regressing Müllerian duct cells in wildtype mice have open chromatin, crenellated nuclei, and swollen organelles [130]. MD,
Müllerian duct epithelial cell. (p) Explant cultures of degenerating Müllerian duct cells
from rats share the same features [133]. Adapted from [235].
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Figure 4. Ultrastructure of the Nucleus

Examples of the NII (A and B; indicated by large arrows) found within striatal neurons that have many indentations in the nuclear membrane
(small arrows) demonstrated with conventional electron microscopy (osmium/uranyl/lead staining). Typically, more than 90% of neurons within
the mouse striatum have a smooth nuclear profile, and all lack any inclusion (C). At higher magnifications, the NII is seen to be a pale staining
structure quite distinct from the more darkly stained adjacent nucleolus (Nu) and surrounding chromatin. Scale bar for (A)–(C) is 2 m and
for (D) is 200 nm.

inherently unnatural settings. I have therefore focused on processes that are genetically
non-apoptotic, and which also have obvious non-apoptotic features in the developing
wild-type animal.
1.5.1. Cell death in the vertebrate nervous system
Initial studies of mice harboring lesions in core apoptotic components, including
Apaf1, the initiator Caspase-9, and the executioner Caspase-3, suggested important
roles for these genes in nervous system development. Apaf1-/-, Caspase-3-/-, and
Caspase-9-/- animals exhibited exencephaly associated with neural tube defects,
and most animals died perinatally or shortly after birth [13,32-35], and presented
with mitotically active immature neurons [110]. Later studies revealed that genetic
background was a strong contributor to these defects, and that mice carrying the same
lesions in other genetic contexts could develop normally to adulthood. For example,
Caspase-3-/- mice in a C57BL/6J genetic background survive to adulthood, but the same
mutation in 129X1/SvJ mice induces perinatal lethality [37]. How then does cell death
still occur? A number of studies suggest that alternative cell death pathways are likely to
be at least as important as apoptosis in these mutants.
While embryonic stem cells (ESCs) lacking Caspase-9 exhibit resistance to
pro-apoptotic agents [32], some mutant cells die and exhibit non-apoptotic LCD-like
morphology, including a crenellated nuclear envelope, uncondensed chromatin,
and swollen organelles (Figure 1-8g), suggesting that a process akin to linker cell
death may be at play. Supporting this, death of post-mitotic spinal cord and brain
stem motoneurons (Figure 1-9a) appears to proceed normally in Caspase-3-/- and
Caspase-9-/- animals even though TUNEL staining decreases [110], suggesting
that caspase-activated DNase (CAD), one of the enzymes responsible for cleaving
chromosomal DNA during apoptosis [111], is not induced. Thus, cells appear to be
dying in the absence of caspase activation. Indeed, dying cells lacking Caspase-3 or
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Figure 1-9. Non-apoptotic cell death occurs in vertebrate development.
(a) In the developing mouse embryo, neurons within the brain and spinal cord (blue)
die. In male mice at E13.5, the Müllerian duct (MD, purple) and the Wolffian duct (WD,

green) are both present in the immature reproductive system. Signal from the testes
cause the Müllerian duct to degenerate by E15.5. (b) Cell death occurs in the inner cell
mass of the blastocyst (yellow) prior to implantation. Uterine epithelial cells die upon
implantation of the blastocyst and may be entosed by the trophoblast cells.
Caspase-9 have different morphologies than wild-type cells, with reduced chromatin
condensation [110]. Similar studies in Bax-/- animals reveal an increase in cell number,
but the extra cells are small and atrophied, are not synaptically connected, and
exhibit crenellated nuclei [112] (Figure 1-8h). In Apaf1-/- mutants, spinal and cranial
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motoneurons, and DRG sensory cell death numbers are normal compared to wild type,
again suggesting that caspase-independent cell death mechanisms are important in the
developing nervous system [113].
As in the mouse, motoneurons are normally produced in excess during chick
spinal cord development, and many subsequently die [114]. Ultrastructurally, these
dying wild-type cells possess either apoptotic or non-apoptotic morphologies, the
latter exhibiting dilated organelles, open chromatin, and an irregular nucleus [115,116]
(Figure 1-8i). Axotomized retinal ganglion cells or peripherally deprived ciliary ganglion
cells have the same indented nuclear structure [117,118] (Figure 1-8j,k). Interestingly,
wild-type chick motoneurons in culture can adopt similar morphologies (Figure 1-8l),
and while these dying cells can be engulfed, they lack cleaved Caspase-3 staining
or TUNEL staining [119]. In vivo, these motoneurons still die in the presence of the
Caspase-3 inhibitor Ac-DEVD-CHO or the stronger pan-caspase inhibitor Boc-D-FMK
(BAF) [120]. Intriguingly, all of the dying cells treated with caspase inhibitors have
a crenellated nucleus, open chromatin, and swollen organelles [120], all features of
LCD (Figure 1-8m).
1.5.2. Cell death in the inner cell mass (ICM)
Cell death is an early occurrence in vertebrate development, and is already
evident in the inner cell mass (ICM), prior to implantation [121] (Figure 1-9b). These cell
deaths in a wild-type mouse blastocyst are characterized by condensed chromatin and
loss of nuclear membrane integrity, but also swelling of the endoplasmic reticulum [122].
Single mutants of apoptotic factors do not seem to block blastocyst development,
suggesting that cell death likely proceeds normally [121]. Supporting this notion, when
hamster or mouse embryos are cultured from the 8-cell stage to the blastocyst stage
in vitro in the presence of the Caspase-3 inhibitor Ac-DEVD-CHO, no noticeable
effects on development are observed [123]. Dying cells in the ICM of wild-type bovine
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blastocysts exhibit a mix of apoptotic and non-apoptotic features [124]. Some dying
cells have condensed chromatin but weak TUNEL staining, while others have moderate
TUNEL staining [124]. Furthermore, only low transcript levels of key apoptotic factors,
including Caspase-3, Caspase-9, Caspase-8 and Fas/FasLG, are detected [124]. Thus,
caspases, and perhaps other apoptotic proteins, may not be required for cell death in
the ICM.
1.5.3. Death of uterine epithelial cells during implantation
At the site of implantation, uterine epithelial cells die and are internalized by
embryonic trophoblast cells [125] (Figure 1-9b). These dying epithelial cells in normal
development exhibit compacted chromatin, but also swollen organelles and irregular
nuclear envelopes [125,126] (Figure 1-8n). One set of studies reported activated
Caspase-3 in TUNEL-positive dying cells in wild-type hamster and mouse uterine
epithelial cells at the site of implantation [123]. Additionally, inhibiting Caspase-3 with
N-acetyl-DEVD-CHO in the uterus stopped implantation in both species, suggesting
that Caspase-3 may be necessary for cell death [123]. However, Caspase-3-/- or
Apaf1-/- adult female mice are fully fertile [37,38]. Furthermore, a subsequent detailed
examination of the process revealed that neither cleaved Caspase-3 nor TUNEL
are detected in dying wild-type epithelial cells immediately adjacent to trophoblast
cells [127]. Entosis, engulfment of a living cell followed by degradation, has been a
suggested mechanism, as the small GTPase ROCK, which controls entosis in cell
culture [128], appears to be required [127]. The ultrastructure of these dying cells was
not reported, but could be used to distinguish among different alternative cell death
mechanisms.
1.5.4. Cell death in the Müllerian duct
In developing mammals, sex specification occurs early in embryogenesis.
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Initially, both sexes form a Wolffian duct (WD), which develops into male urogenital
structures, and a Müllerian duct (MD), which gives rise to the female reproductive
tract. In females, the WD degenerates, whereas the MD regresses in males [129]
(Figure 1-9a). MD regression occurs at day E13.5 [130], and is initiated by the secreted
TGF-β protein AMH (anti-Müllerian hormone) [131]. In the absence of AMH, the MD
persists, and results in female organs alongside the male urogenital system. This leads
to male infertility, as the ectopic female organs physically block sperm release [132].
The morphology of dying wild-type MD epithelial cells in rats, mice, and rabbits,
is entirely non-apoptotic: chromatin in degenerating cells does not condense, and
the nuclear envelope is crenellated [130,133,134] (Figure 1-8o). These features are
highly reminiscent of linker cell death in C. elegans, suggesting that MD degeneration
proceeds in a similar fashion. Degeneration of female rabbit WD cells is also
accompanied by crenellated nuclei [134]. MD and WD degeneration can be faithfully
reproduced in an organ culture system, and dying cells here exhibit open chromatin and
nuclear crenellation [135] (Figure 1-8p).
Regressing wild-type MD cells are TUNEL-positive [136], and cleaved Caspase-3
is detected in some dying cells [132]. However, neither Caspase-3 nor other apoptosis
mutants are reported to harbor defects in urogenital tract development. There are
conflicting reports regarding the sterility of Apaf1-/- mutants males; however, not all
males are infertile [38,39]. Caspase-3-/- male mice in the C57BL/6J genetic background
are fully fertile [37]. Thus, it is possible that LCD is the main cell death mechanism
during MD and WD degeneration, with Apaf1 and Caspase-3 either playing minor roles,
or specifically promoting cell corpse degradation (e.g. [120]).
While the genes directly driving MD epithelial cell death are unknown, some of
the upstream signaling events have been explored. Wnt7a signaling from MD epithelial
cells allows surrounding mesenchymal cells to respond to testes-derived AMH [137],
likely by regulating expression and/or activation of receptors in the mesenchymal
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cells [138-140]. Receptor engagement leads to activation of SMAD1/5/8 proteins, which
in turn induce expression of Wnt4, and possibly other Wnts [140]. Possible autocrine
signaling then leads to the activation of β-catenin, which may dimerize with LEF1/TCF
to promote regression in the adjacent epithelial cells [136]. β-catenin accumulates
in the mesenchymal cytoplasm, and is present near the plasma membrane of MD
epithelial cells [136]. Mesenchyme-specific knockdown of β-catenin prevents MD
degeneration [132]. While both MD regression and linker cell death in C. elegans
use β-catenin signaling to initiate cell death, β-catenin appears to function cell nonautonomously in the MD.
The matrix metalloproteinase MMP2 may be involved in signaling to initiate
regression [141]. Mmp2 is expressed at higher levels in the mesenchyme of males, and
this increased expression is abolished in the absence of AMH [141]. In organ culture,
blocking MMP2 activity prevents MD degeneration, while activating MMP2 causes
degeneration, even in the absence of AMH [141]. However, MMP2 mutant mice are
fertile, suggesting other genes may be involved [142]. Roles for MMPs in linker cell
death have not been described, but the adjacent gonad is known to secrete these
proteins [143].
Together, the examples described make a compelling case for the prevalence of
caspase-independent non-apoptotic cell death during vertebrate development, with LCD
playing, perhaps, an important role.
1.6. Phagocytosis and degradation of dying cells
After cell death, the dying corpse must be recognized and engulfed by
neighboring cells or professional phagocytes. Clearance of cells undergoing
programmed cell death is important during development of multicellular organisms,
and failure to remove dying cells is implicated in developmental abnormalities [144]
and autoimmune disease [145]. Studies of the nematode C. elegans uncovered
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genes required for engulfment and degradation of cells dying by apoptosis [146-151].
Homologous genes regulate apoptotic cell clearance in Drosophila and vertebrates, as
do a number of species-specific genes [152-154].
1.6.1. Recognition and engulfment of apoptotic corpses
In C. elegans, neighboring cells, rather than specialized phagocytes, engulf dying
cells [155,156]. Two distinct, parallel pathways are responsible for apoptotic corpse
recognition [146,157]. In pathway A, ced-1/Megf-10, ced-6/Gulp, and ced-7/Abca1
function at the cell membrane to recognize the cell corpse, likely through phosphatidyl
serine (PS) exposure [158-160] (Figure 1-10a). PS is also actively exposed on cells
dying by necrosis in C. elegans, and requires the same engulfment machinery as
apoptotic cells, as well as necrotic specific genes [161].
In pathway B, ced-2/CrkII, ced-5/Dock180, and ced-12/Elmo function within
the cytoplasm of the phagocyte to promote activation of ced-10/Rac [162-165]
Clathrin and its adaptor in engulfment

RESEARCH ARTICLE 3241

Fig. 9.
CHC-1 and
EPN-1 Phagocytosis
promote actin polymerization
response to apoptotic
CED-1 signaling.corpses.
(A) Two parallel pathways that regulate apoptotic-cell
Figure
1-10.
of C. inelegans
engulfment. The mammalian homologs of C. elegans proteins are indicated in parentheses. (B) Model depicting how CHC-1 and EPN-1 regulate cytoskeleton
(a) In C.
two parallel
engulfment
ofpathway
apoptotic
corpses.
polymerization
andelegans,
promote pseudopod
extension. Inpathways
response to themediate
‘eat me’ signal,the
CED-1
initiates a signaling
that recruits
EPN-1 to the plasma
membrane at the site of engulfment through PtdIns(4,5)P2 and perhaps direct interaction. EPN-1 further recruits CHC-1 to the same site. CHC-1 oligomerizes
elegans
proteins
in black,
mammalian
homologs
inaround
blue.the(b)
Actin
into aC.
scaffold
upon which
actin molecules
assembleand
into polymers,
driving pseudopod
extension
apoptotic
cell.(green) is

polymerized in the engulfing cell to extend pseudopods around the corpse, mediated by
generation
of membrane
curvature coupling
to match theproteins.
shape of the “Eat-me”
prey. another
crucial pseudopod
event regulated
by CED-1. The
clathrin
and unknown
signals,
such asextension
phosphatidyl
serine
The curvature-generating mechanism dedicated to apoptotic-cell similar category of actin-remodeling defects resulted from
are exposed
on the Epsin
dyingis cell.
Adapted
from [168].
engulfment
remains unclear.
an efficient
membrane
inactivating ced-1, ced-6, dyn-1, epn-1 or chc-1, together with the
generator (Ford et al., 2002; Boucrot et al., 2012). We propose that,
during engulfment, EPN-1 induces membrane curvature, whereas
the associating clathrin scaffold and the subsequently attached Factin further stabilize the curvature. The cooperative actions of
26
EPN-1, CHC-1 and F-actin thus result in the continuous extension
of pseudopods along apoptotic-cell surfaces (Fig. 9B).

essential roles of CED-1, CED-6 and DYN-1 in recruiting EPN-1
and CHC-1, indicate that the CED-1 pathway drives EPN-1 and
CHC-1 to regulate specific aspects of actin remodeling underneath
pseudopod membrane.
Rat CED6 was reported to interact with clathrin heavy chain
(Martins-Silva et al., 2006). Recently, Drosophila Ced-6 was found

(Figure 1-10a). Genes from these two pathways have also been implicated
in axon pruning and the diurnal renewal of photoreceptor cells, among other
processes [166,167].
In WT embryos, engulfment, which begins with the budding of pseudopods
and ends when the phagocytic cup closes completely, takes on average 7 min [168].
Pseudopod extension around embryonic apoptotic corpses relies in part on the
C. elegans clathrin gene (chc-1) and epsin (epn-1), which is able to induce membrane
curvature [168] (Figure 1-10a,b). Both genes act downstream of the ced-1 pathway,
along with the dynamin dyn-1 [149,168].
Many of the genes identified in C. elegans have functional homologs in
both Drosophila and vertebrates [169-171]. In these other organisms, professional
phagocytes exist alongside ‘amateur’ phagocytes. For example, in Drosophila,
macrophage-like plasmatocytes migrate freely within the embryo to engulf foreign
particles and dying cells [172]. The CD36-like receptor Croquemort is required in
Drosophila for the engulfment of apoptotic corpses but not bacteria, suggesting that
different receptors are required for different particles [152].
1.6.2. Degradation of apoptotic corpses
Once a dying corpse is internalized by a neighboring cell or professional
phagocyte, its compartment is progressively acidified and recycled (Figure 1-11).
Degradation of a refractile apoptotic embryonic corpse in C. elegans takes
approximately 40-50 min in wild-type animals [149,173,174].
After internalization, a series of membrane composition changes and changes
in associated proteins results in the progressive acidification of the phagosome and
eventual degradation of the corpse in C. elegans embryos. Initially, phosphatidylinositol
3-phosphate (PI3P) is produced on nascent phagosomes by the PI3-kinases piki-1 and
vps-34 in C. elegans [175]. PI3P is loaded onto the phagosome in a wavelike fashion,
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Figure 1-11. Degradation of internalized apoptotic corpse.
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which requires the PI3-phosphatase MTM-1 [175]. This allows the recruitment of FYVEdomain containing proteins such as the sorting nexins SNX-1, SNX-6 and LST-4/SNX-9
[176]. Mutations in these genes lead to an excess of engulfed but undegraded apoptotic
corpses.
Next, early endosomes marked by the small GTPase RAB-5 are recruited and
fuse to the nascent phagosome [147]. These RAB-5-positive endosomes are recruited
immediately after phagosome sealing in C. elegans, likely by DYN-1 [147,174]. RAB-5
to RAB-7 conversion by SAND-1 and CCZ-1 allows the fusion of late endosomes and
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eventually lysosomes to the corpse-containing phagosome [148,177]. RAB-7 may
function downstream at the lysosome-phagosome fusion step, and remains on the
phagosomal membrane until the corpse is completely degraded [149,150].
RAB-2 promotes the fusion of lysosomes to the phagosome, and also plays a
separate role in acidification of the phagosome lumen [149,151]. RAB-14 plays similar
roles to RAB-2, and the two proteins likely function in partially redundant pathways for
recruiting and tethering lysosomes to phagosomes [150,151]. Proteomic approaches
in cell culture have revealed more than a dozen Rabs associated with the phagosome,
suggesting that other, yet-to-be identified, RAB proteins are also involved [178,179].
In mammalian systems, most of the studies of phagosome maturation in
macrophages have focused on the internalization of opsonized latex beads or bacteria,
and many of the genes and pathways discussed above are conserved in these
processes [179]. The core molecules are the same, with roles for PI3-kinase, Rab5 and
Rab7 well-established [180]. There is reason to suspect that the process and dynamics
of apoptotic corpse engulfment differs from engulfment of foreign objects, however,
especially since engulfment and degradation of cells dying by apoptosis does not elicit
an immune response [181].
1.6.3. Engulfment and degradation of non-apoptotic corpses
While the molecular and genetic characterization of some non-apoptotic cell
death processes has advanced considerably, whether common clearance mechanisms
are used for apoptotic and non-apoptotic dying cells remains a major open question. It
has been shown that apoptotic engulfment genes in C. elegans are not responsible for
engulfment of the linker cell corpse [82], but whether these and other genes function in
linker cell corpse degradation is unknown. The genes responsible for both the death and
degradation of the linker cell are the basis of my thesis.
I was interested in how the polyglutamine protein PQN-41C induces cell death,
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so I investigated the function PQN-41C by determining the role of its interacting
partners, which is discussed in Chapter 2. To identify genes necessary for death and
degradation, I carried out a forward genetic screen and identified the protein networks
for two small GTPases, and their role in phagosome maturation; these results comprise
the bulk of my thesis and are discussed in Chapter 3. Lastly, I found that the caspase
CED-3 has an unknown and surprising role in linker cell corpse degradation, but not
death, which is discussed in Chapter 4. In Chapter 5, I synthesize these results and
place them into a broader context of non-apoptotic cell death and degradation, and I
speculate on how these processes may be conserved in mammalian systems.
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2. PQN-41C interacts with an inhibitor of linker cell death, HPK-1
2.1. Summary
PQN-41C is a polyglutamine protein required for efficient linker cell death.
PQN-41C is comprised almost entirely of coiled coil domains [87], which can act as
protein binding platforms [182]. To determine additional binding partners of PQN-41C,
I carried out a protein interaction screen using a yeast two-hybrid system against a C.
elegans cDNA library. I recovered 33 possible interacting partners, and I performed
RNAi against each of these genes to identify putative roles in linker cell death. I focused
on hpk-1, a gene encoding a homeodomain protein kinase, which appears to function
as an inhibitor of linker cell death. I performed epistasis experiments with known linker
cell death genes and found that loss of hpk-1 suppressed the linker cell survival defects
of known regulators. However, hpk-1 did not suppress defects in hsf-1(lf), suggesting
that HPK-1 acts upstream or in parallel to HSF-1. Subsequent analysis revealed that
HSF-1-GFP fails to form stress granules upon heat shock in the absence of hpk-1.
Additionally, the heat-shock-related linker cell survival defect is suppressed in the
absence of hpk-1. Together, these results suggest that HPK-1 promotes the heat shock
function of HSF-1, and inhibition of HPK-1 is required for efficient cell death, which may
be regulated through PQN-41C.
2.2. PQN-41C interacts with proteins of different functions
Previous work in the lab suggested that the long isoforms of PQN-41, A and B,
promote cell survival, while the shorter isoform PQN-41C promotes cell demise [87].
All of these isoforms share a polyglutamine repeat region, while the A and B isoforms
have long N-terminal tails with coiled-coil domains [87]. Both coiled-coil domains and
polyglutamine repeats are thought to act as protein binding platforms [183], raising the
possibility that the distinct interactomes of each of these PQN-41 isoforms may confer
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their opposing functions. To try and determine these interactomes, I attempted a yeast
two-hybrid screen using each of these isoforms as bait, but I failed to see expression
of LexA-PQN-41A or LexA-PQN-41B (Figure 2-1a). I did see expression of LexAPQN-41C, which did not autoactivate under His-Leu-Trp-Ade- conditions (Figure 2-1b),
so I decided to continue screening using PQN-41C only.
Using a C. elegans cDNA library from L4 hermaphrodites, I transformed
9.3x106 colonies, and I recovered 71 candidate clones over a 9-day screening period
(Table 2-1). These clones represent 38 genes, with gene ontology classifications of
proteolysis, PQN-domain, ubiquitin-related, DNA-related, and RNA-related, among
others (Table 2-1).
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I identified PQN-41C as interacting with another isoform of PQN-41 in the yeast
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Figure 2-1. Controls for PQN-41C yeast two hybrid screen.
(a) Total protein from yeast cells expressing LexA-PQN-41B, LexA-PQN-41C, or
LexA-p53 (positive control) was extracted and probed with an anti-LexA antibody to
determine protein expression levels. (b) Yeast expressing p53 and large T antigen
(positive control) or PQN-41C and empty vector (ev) were tested for interaction or selfactivation, respectively, on minimal media plates.
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Table 2-1. List of PQN-41C interacting proteins and their surviving linker cell
phenotype upon knockdown.

1
1
2
1
1
2
2

Proteolysis
Proteolysis
Proteolysis
Proteolysis
Proteolysis
Coil-coiled domain
Coil-coiled domain

RNAi phenotype
(N)
3% (137)
6% (95)
4% (91)
6% (100)
n.d. (arrest)
8% (130)
18% (96)***
11% (127)*

R11A8.7

1

Coil-coiled domain

6% (103)

pqn-59

9

Gene
empty vector
asp-3
F32A5.3
K10C2.1
F57F5.1
nep-17c
pqn-41
npp-4

No. of
Y2H hits

Function

tag-214
F52G3.1
sao-1

1
1
1

Coil-coiled domain/
proteolysis
Coil-coiled domain
Coil-coiled domain/
DNA-related
Ubiquitin-related
Ubiquitin-related
Ubiquitin-related

etr-1

2

RNA-related

H34I24.3
pqn-85

1
1

10% (81)
6% (88)

18% (82)**
n.d. (slow growth)
6% (82)
11% (158)*
9% (87)

Notes
1
1
1
1
1
Y2H clone
corresponds to
b/c/e isoforms; 1

2

Y2H clone
corresponds to
e/f/g isoforms; 1

asd-1
1
RNA-related
3% (97)
asd-2
2
RNA-related
2% (118)
1
pes-4
1
RNA-related
10% (94)*
chd-7
2
DNA-related
14% (119)*
1
zfp-1
1
DNA-related
16% (101)**
tag-153
7
DNA-related
10% (167)*
2
eef-2a
1
DNA-related
n.d. (arrest)
T19D12.2
1
DNA-related
5% (76)
a/c isoforms; 1
aco-2
1
33% (79)***
a/c isoforms
aldo-2a
1
15% (95)*
meg-1/2
3
7% (150)
1
1
M02E1.1a
2
Unknown function
3% (104)
hpk-1
4
kinase
0.7% (136)
C18E3.9
1
Unknown function
4% (74)
clec-49/50
1
lectin
3% (144)
1
F57F4.4
1
7% (160)
1
gdi-1a
1
8% (150)
1
yars-1
1
tRNA synthetase
4% (134)
vit-4
1
Yolk protein
Didn’t assay
vit-3
1
Yolk protein
Didn’t assay
vit-6
1
Yolk protein
Didn’t assay
1. cloned targeting region into L4440 from Y2H (Ahringer clone incorrect or nonexistent). 2. cloned from cDNA library (Ahringer clone incorrect or non-existent).
**: P<0.0001, **: p<0.001, *: p<0.05, Fishers exact test. RNAi clones obtained
from [243] unless otherwise noted. Strain contains rrf-3 mutation for increased RNAisenstivity, him-5 for males, and a GFP linker cell marker.
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two-hybrid screen (Table 2-1), so I tested the other two isoforms for interaction. I found
that PQN-41A-LexA interacts with PQN-41B and PQN-41C, and that PQN-41C indeed
interacts with itself (Figure 2-2). This preliminary result suggests that perhaps PQN-41C
forms dimers or oligomers to drive its cell death function.
2.2.1. Knockdown of some potential interacting partners causes a linker
cell survival defect
I knocked down each of the candidate interacting partners in an RNAi-sensitized
background (Table 2-1). Seven genes gave a significant number of surviving linker cells
upon knockdown, and one gene appeared to accelerate linker cell death or degradation.
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Figure 2-2. PQN-41C interacts with itself.
Interactions between the PQN-41 isoforms were tested using a yeast two-hybrid
assay. LexA-tagged components listed above the interaction spot, and GAD-tagged
components listed below the interaction spot. LexA was located N-terminally unless
otherwise noted (labeled as (c)). Left panel shows effect of transformed proteins on
yeast growth, and right panel shows growth on minimal media, indicating physical
interaction. p53 + large T antigen included as a positive control.
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These candidates were investigated further and are discussed below.
2.2.1.1.

aco-2

Knockdown of the mitochondrial aconitase aco-2 increased the number of
surviving linker cells (SLCs) to 33% (Table 2-1). In these animals, the linker cell often
detached from the gonad, so that the gonad itself never completely migrated to the
tail of the animal (Figure 2-3). The linker cell failed to migrate completely in 18% of
the animals (N=8/45). The spermatids were also defective, with 98% of spermatids
appearing to have excessive vacuolization (N=44/45, Figure 2-3). Knockdown of aco-2
in a pqn-41(ns294) background was additive, suggesting these genes function in the
same pathway (Table 2-2). aco-2 appears to function cell-autonomously, as knockdown
aco-2 RNAi
2h adult male

vacuolated
spermatids
end of
gonad

Linker cell detaches
and migrates without
gonad

Figure 2-3. Knockdown of aco-2 leads to incompletely migrated gonads and
vacuolated spermatids.
L1 synchronized RNAi-sensitized animals were fed bacteria expressing doublestranded aco-2 RNA. Males were scored 2h after the L4 to adult transition. Image is a
representative example. Strain contained rrf-3(pk1426) II; him-8(e1489) IV; qIs56 V.
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Table 2-2. zfp-1 acts synergistically with pqn-41.
%Surviving
Predicted if additive
linker cells (N)
empty vector
25% (107)
aco-2
50% (102)
50%
pqn-85
39% (83)
39%
zfp-1
44% (62)*
37%
aldo-2
22% (49)
36%
chd-7
29% (56)
36%
tag-153
12% (42)
33%
* = results indicate synergy. Strains contain pqn-41(ns294), him-5(e1490) for
males and qIs56 linker cell marker. Animals were scored 0-2h after the L4 to
adult transition.
Gene

specifically in the linker cell resulted in a significant increase of SLCs (Table 2-3). The
migration defect appears to be cell non-autonomous, however (Table 2-3). I obtained
a temperature sensitive allele or1565ts from Bruce Bowerman’s lab, but these animals
failed to grow after hatching at 25oC. A more sensitive time course should be developed,
perhaps shifting to 25oC prior to the commitment to cell death at the L3 or early L4 larval
stage.
2.2.1.2.

zfp-1

Knockdown of the zinc finger protein zfp-1 resulted in 16% SLCs (Table 2-1). I
obtained a deletion allele of zfp-1, ok554, which skips exons 6 and 7; these exons do
not include the zinc finger domain or the PQN-41 interacting region, so ok554 may be a
hypomorphic allele, as confirmed by a weaker SLC defect in these animals (Table 2-4).
zfp-1 appears to function cell autonomously in linker cell death, as knockdown
specifically in the linker cell caused a significant increase in the number of SLCs,
although there was also an increased number of migration defective cells (Table 2-3).
To determine its genetic interaction with pqn-41, I knocked down zfp-1 in RNAisensitized pqn-41(ns294) animals. Interestingly, the two genes appear to function
synergistically, together having a defect of 44% surviving linker cells (Table 2-2).
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Table 2-3. aco-2, zfp-1, eef-2, and tag-214 function cell autonomously.
Gene
e.v.
aco-2
pqn-85
zfp-1
aldo-2
chd-7
tag-153
hpk-1
eef-2
F57F5.1
tag-214

WT background
%SLC (N)
3% (157)
21% (43)*
13% (53)*
13% (46)*
8% (51)
4% (46)
n.d.
n.d.
let
let
slow growth

LC-specific RNAi
%SLC (N)
11% (47)
20% (91)*
9% (114)
23% (47)*
n.d.
11% (55)
3% (40)
5% (70)
20% (54)*
7% (119)
18% (56)*

%LCs with
migration defect
0
1%
2%
9%
n.d.
2%
0
0
n.d.
n.d.
n.d.

n.d. = not determined, let = lethal, e.v. = empty vector; * p<0.5, Fishers exact test,
Strains contain rde-1(ne219) for abrogation of systemic RNAi, nsIs387 for RNAi in
the linker cell only, him-8(e1489) for males, and qIs56 as a linker cell marker. Animals
were scored 0-2h after the L4 to adult transition. Knockdown of genes in a wild-type
background (not RNAi-sensitized, no rde-1 mutation) included as reference.

Animals doubly mutated for zfp-1(ok554) and pqn-41(ns294) together developed slowly,
and had incomplete male tail development. This developmental defect precluded me
from scoring the SLC phenotype effectively in this background. However, this result
suggests these genes function together in similar processes during development, as
well as in LCD.
2.2.1.3.

pqn-85

Knockdown of the NIPBL ortholog pqn-85 in an RNAi-sensitized background
resulted in 18% SLCs (Table 2-1). Decreasing pqn-85 levels in pqn-41(n294); rrf-3
animals caused an additive increase of SLCs (Table 2-2). Knockdown of this gene
in a wild-type background, however, only had a 13% SLC defect, and knockdown
only in the linker cell had no significant increase in the defect compared to empty
vector control (Table 2-3). I obtained two alleles of pqn-85, tm2338 and tm2334/+.
37

Table 2-4. Genetic mutants of Y2H hits do not recapitulate their RNAi phenotype
in most cases.
Genotype
Wild type

%SLC (N)
3% (157)

zfp-1(ok554)

11% (47)

chd-7(tm6138)
chd-7(tm6139)
chd-7(gk290)
chd-7(gk306)
tag-153(ok699)
aco-2(or1565ts)^
hpk-1(pk1393)

4% (53)
2% (49)
12% (50)
5% (38)
4% (26)
n.d.
6% (87)

Notes
Weak allele; skips exon 6 and 7 which do not
include ZnF or interacting region
In frame deletion of exon 3
In frame deletion
In frame deletion at C term
In frame deletion at C term
Strong LOF (out of frame deletion)
Temp. sensitive allele
Putative null

^obtained from Bruce Bowerman; n.d. = not determined. Animals were scored 0-2h after
the L4 to adult transition. Strains also contain either him-5(e1490) or him-8(e1489) for
males, and qIs56 or nsIs65 linker cell marker.

Unfortunately, tm2338 did not have the annotated mutation, and tm2334 animals were
inviable as homozygous animals. Therefore, I was unable to adequately follow up on
this gene.
2.2.1.4.

chd-7

chd-7 encodes a chromodomain helicase, homologous to mammalian CHD8.
Mutations in CHD8 are a risk factor for autism [184]. Knockdown of chd-7 in an RNAisensitized background resulted in a 14% surviving linker cell (SLC) defect. I obtained
four alleles of chd-7, all of which resulted in in-frame deletions of various parts of the
protein (Table 2-4). The defects ranged from 2% SLC to 12% SLC, but all alleles were
unlikely to be true null alleles, based on predicted protein translation. Unfortunately,
knockdown of chd-7 in a wild-type RNAi background or in the linker cell specifically
did not increase the number of SLCs compared to WT (Table 2-3), suggesting that the
original RNAi phenotype may have been a false positive.
To determine if an odd genetic interaction was occurring between chd-7 and
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rrf-3, the gene that confers RNAi sensitivity when mutated, I crossed chd-7(gk290)
and chd-7(gk306) to rrf-3(pk1426), and found that the double mutants had a significant
number of SLC compared to the chd-7 mutants alone (chd-7(gk290); rrf-3(pk1426): 17%
(N=46); chd-7(gk306); rrf-3(pk1426): 14% (N=58)). This result suggests that there may
be an unknown genetic interaction between chd-7 and rrf-3 that is somehow influencing
linker cell survival. Knocking down chd-7 in a pqn-41(ns294); rrf-3 background did not
significantly increase the number of SLCs compared to each gene alone (Table 2-2).
2.2.1.5.

tag-153

tag-153 encodes a NOT-domain-containing protein, which is typically found
in negative regulators of transcription [185]. It is homologous to CNOT2 in humans.
Knockdown of tag-153 in an RNAi-sensitized background resulted in a weak phenotype
of 10% SLC (Table 2-1). I obtained a strong loss-of-function allele, ok699, which
encodes a large deletion that results in an out-of-frame coding sequence. This allele
did not recapitulate the RNAi phenotype, however, and had a SLC defect similar to
wild type (Table 2-4). Intriguingly, linker-cell-specific knockdown of tag-153 resulted
in a decreased number of SLC compared to the empty vector control (Table 2-3);
knockdown of tag-153 in pqn-41(ns294); rrf-3 animals also decreased the number of
surviving cells by half (Table 2-2).
2.2.1.6.

aldo-2

aldo-2 encodes an aldolase, a glycolytic enzyme. Knockdown in an RNAi
sensitized background resulted in a 15% SLC defect, but only 8% when knocked
down in an otherwise wild type background (Tables 2-1, 2-3). Knockdown of aldo-2 in
pqn-41(ns294); rrf-3 animals did not enhance the pqn-41 phenotype (Table 2-2). aldo-2
is expressed in many cells in the animal, although I did not see expression within the
linker cell specifically.
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2.2.1.7.

Knockdown of tag-214, F57F5.1, and eef-2 resulted in slow growth

or larval lethality
Knockdown of tag-214, a gene encoding an E3 ubiquitin ligase similar to RBBP6,
F57F5.1, a gene encoding an ortholog of cathepsin B, or eef-2, a gene encoding
the translation elongation factor EF-2, resulted in either larval lethality or slow larval
development (Table 2-1). Because of this, I was unable to determine the effect on linker
cell death using whole animal knockdown experiments. Therefore, I knocked down
each of these genes in a linker-cell-specific manner, and I found that both eef-2 and
tag-214 had a significant number of surviving cells when knocked down in the inker
cell (Table 2-3).
2.2.2. Knockdown of some potential interacting partners reduces the
number of aberrantly surviving cells
Knockdown of two genes, asd-2, which encodes an RNA binding protein similar
to mammalian QKI, and hpk-1, which encodes a homeodomain protein kinase similar to
HIPK1/2 in vertebrates, did not have a SLC defect (Table 2-1). Instead, knockdown of
these genes resulted in a decreased number of dead or dying linker cells, suggesting
that these genes may be inhibitors of cell death (asd-2: 42% remaining corpses,
p=0.0011 compared to WT; hpk-1: 17% remaining corpses, p<0.0001 compared to WT,
Fishers exact test). Because of the weaker phenotype of asd-2, I decided to focus on
the role of hpk-1 in linker cell death first.
2.3. PQN-41C interacts with the homeodomain protein kinase, HPK-1, an
inhibitor of linker cell death
I recovered four independent yeast two-hybrid colonies of hpk-1, with the
interacting region near the Ser/Thr kinase domain (Figure 2-4). A literature search of
hpk-1 homologs revealed a putative interaction with the heat shock factor HSF-1, a
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3.1 kb

5.4kb
S/T kinase domain

hpk-1a
hpk-1b
hpk-1c
Y2H hit
RNAi target
deletion pk1393

Figure 2-4. Genetic information for hpk-1.
hpk-1 has three isoforms, all of which contain a Ser/Thr kinase region. Shown is the
location of the Y2H interacting fragment (green), the location of the RNAi targeting
construct (purple), and the out-of-frame deletion caused by pk1393 (yellow).

known linker cell death gene (see Discussion). Therefore, I wanted to determine how
hpk-1 is involved in linker cell death, as well as its interactions with known linker cell
death genes, including HSF-1.
2.3.1. Knockdown of hpk-1 decreases the number of surviving cells
As mentioned above, knockdown of hpk-1 in an RNAi-sensitized background
decreased the number of SLCs and remaining corpses 2h after the L4 to adult transition
compared to WT (Table 2-1). Knockdown specifically in the linker cell also caused
a decrease in the number of surviving cells, compared to the empty vector control
(Table 2-3). I obtained a putative null of hpk-1, pk1393, which deletes the majority of the
kinase domain (Figure 2-4). This allele had a similar number of SLCs compared to WT
(Table 2-4), and was used for further genetic interaction studies.
2.3.2. Knockdown of hpk-1 suppresses the linker cell death defects of
regulatory genes required for LCD
I wanted to determine how hpk-1 interacts with known linker cell death genes, so
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I knocked down hpk-1 in strains where those genes were mutated. Knockdown of hpk-1
in pqn-41(ns294); rrf-3 animals resulted in half the number of SLCs compared to pqn41 alone (Figure 2-5). Similar results were seen with the upstream activator of pqn-41,
sek-1(ag1) animals, and in the Wnt egl-20(n585) (Figure 2-5).
Next, I wanted to verify these results using genetic double mutants. Because
hpk-1 and other cell death genes result in male infertility [82,185], I used artificial
insemination to generate these strains (see Methods). pqn-41(ns294); hpk-1(pk1393)
double mutants only had a slight decrease in SLCs compared to pqn-41(ns294) alone
(Table 2-5). This difference in phenotypes between the genetic mutants and the RNAi
phenotype could perhaps be explained by the fact that ns294 is not a complete null of

% 2h adults with surviving linker cell
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pqn-41(lf) pqn-41(lf) sek-1(lf) sek-1(lf) egl-20(lf) egl-20(lf) hsf-1(lf)
+ hpk-1
+ hpk-1
+ hpk-1
RNAi
RNAi
RNAi
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hsf-1(lf)
+ hpk-1
RNAi

=N

Figure 2-5. Knockdown of hpk-1 suppresses the surviving linker cell defects of
known linker cell death regulators.
Linker cell survival in indicated genotypes. Animals scored 0-2 h after the L4 to adult
transition. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). Number of
animals scored inside bars. Error bars, standard error of the proportion. n.s., p>0.05,
*, p<0.05, Fisher’s exact test.
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pqn-41.
Despite multiple attempts, I was unable to generate double sek-1(ag1)
hpk-1(pk1393) animals, suggesting that these genes are synthetically lethal. Double egl20(n585); hpk-1(pk1393) animals recapitulated the RNAi phenotype, with loss of hpk-1
suppressing the egl-20 phenotype by half (Table 2-5). I also examined bar-1(ga80)
hpk-1(pk1393) animals and found that hpk-1 enhanced the bar-1 defect to almost
100% (Table 2-5). Oddly, application of RNAi in bar-1(ga80) animals also enhanced the
SLC defect (91% SLCs in empty vector RNAi (N=55) compared to 56% SLCs with no
RNAi application (N=41)), suggesting that lacking bar-1 and undergoing a stress-related
event at the same time may affect linker cell death.
Knocking down hpk-1 by RNAi did not suppress defects in hsf-1(sy441) or
let-70(ns770), however, suggesting HPK-1 functions upstream or in parallel to HSF1 (Figure 2-5, [187]). Double hsf-1(sy441); hpk-1(pk1393) genetic mutants were
indistinguishable from hsf-1(sy441) animals as well (Table 2-5).
2.4. HPK-1 acts upstream or in parallel to HSF-1
The epistasis data between hpk-1 and known linker cell death genes suggested
that hpk-1 acts upstream or in parallel to hsf-1. Therefore, I investigated the relationship

Table 2-5. hpk-1(pk1393) suppresses defects of some linker cell regulatory genes.
Genotype
%SLC (N)
pqn-41(ns294)
20% (44)
pqn-41(ns294); hpk-1(pk1393)
16% (77)
egl-20(n585)
50% (46)
egl-20(n585); hpk-1(pk1393)
24% (90)
bar-1(ga80)
56% (41)
bar-1(ga80) hpk-1(pk1393)
92% (76)
hsf-1(sy441)
25% (49)
hsf-1(sy441); hpk-1(pk1393)
20% (41)
Animals were scored 0-2h after the L4 to adult transition. Strains also contain
him-5(e1490) for males, and qIs56 linker cell marker.
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between HPK-1 and HSF-1 further with Mohammad Alam, a rotation student at the time.
2.4.1. HSF-1 fails to form heat shock granules in the absence of hpk-1
In yeast, the HPK-1 homolog Yak1 phosphorylates Hsf1 to enhance its DNA
binding activities [188]. We wanted to determine if something similar was occurring in
C. elegans, so we examined the formation of HSF-1-GFP granules upon heat shock,
which can be used as a proxy for DNA binding [189]. We found that these granules
failed to form in hpk-1(pk1393) animals after an 8 min heat shock at 35oC, suggesting
that HPK-1 is required for HSF-1 granule formation (Figure 2-6).
2.4.2. The linker cell dies appropriately after heat shock in the absence of
hpk-1
Because of the dual role that HSF-1 plays in both cell survival and cell death,
linker cell death is sensitive to changes in temperature and stress events immediately
WT

hpk-1(pk1393)

Figure 2-6. HPK-1 is required for HSF-1 granule formation after heat shock.
HSF-1-GFP granule formation was examined in wild-type (left) and hpk-1(pk1393)
(right) animals. Animals were heat shocked for 8 min at 35oC and examined immediately
after for formation of nuclear puncta. Inset shows increased magnification of boxed
nucleus.
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prior to cell death onset [85]. In wild-type animals, a brief heat shock 4h prior to LCD
resulted in a 13% surviving linker cell defect (N=61), in support of previously published
results [85]. In hpk-1(pk1393) animals, however, the linker cell dies appropriately after
heat shock (6% SLC, N=120). This result suggests that HPK-1 is required to drive the
heat shock response of HSF-1, and its absence allows HSF-1 to carry out its pro-death
function, even when the heat shock response has been activated.
2.5. Discussion
From a protein interaction screen, I recovered 33 putative interactors of
PQN-41C. pqn-41 is expressed in many cells within the animal [87]. Therefore, these
proteins could be interacting with PQN-41C in the linker cell, or in non-death-related
functions of PQN-41C, such as egg laying (Andrew Schwendeman, unpubl. data). To
determine which genes function to linker cell death, I knocked down each of the putative
interacting proteins in an RNAi-sensitized background. I found that knockdown of ten
of these genes had a significant number of surviving linker cells. Additionally, two of the
candidate genes caused a decrease in the number of surviving cells and cell corpses
upon knockdown.
One immediate question that comes to mind is why were these ten genes
not recovered from the genome-wide RNAi screen carried out by Elyse Blum and
Mary Abraham? For five of these genes, the answer is simple: they were either
misrepresented or missing from the original RNAi screening library. I generated these
RNAi clones myself. Another possibility is that because the original RNAi screen was
carried out under the dissecting scope without a close watch on time, some of the
weaker candidate genes were missed. My subsequent screen was performed under
high magnification, exactly 2h after the L4 to adult transition. This step is crucial for
detecting genes with weak phenotypes (<20% surviving linker cells). Lastly, some of the
genes I recovered could also be false positives, as some of the genetic mutants I tested
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do not phenocopy the RNAi data.
As a next level of stringency, I wanted to test which of the ten genes I isolated
functioned cell-autonomously. I integrated an extrachromosomal array carrying
mig-24p::rde-1 in an rde-1(ne219) background to examine linker cell specificity. This
strain also allowed me to examine the linker-cell-specific defects of the three genes that
caused lethality upon RNAi. This next round of screening revealed that aco-2, zfp-1,
eef-2, and tag-214 function cell autonomously. tag-214 is a particularly intriguing result,
as it encodes an E3 ubiquitin ligase, and may be an interesting gene to follow up on in
the future.
From these different tests, I isolated a few candidate genes that may be worthy
of future study. The aconitase, aco-2, is responsible for the 2-step dehydration/
hydration reaction that converts citrate to isocitrate in the Krebs cycle [190]. The human
homolog, ACON2, is implicated in human prostate cancer and neurodegenerative
disorders, and downregulation is observed in Huntington’s mouse models and patients
[191,192]. Knockdown of aco-2 caused the largest surviving linker cell defect of all the
genes tested; these animals also had an interesting phenotype where the linker cell
would detach from the gonad and continue migrating on its own. A major question that
remains is whether the defect in aco-2 is caused by a general defect in metabolism or
is more specific to linker cell death. While initially I considered that not having enough
ATP would be a reason for a cell to die, it is likely that linker cell death is an energydependent process. Perhaps linker cell death cannot be carried out without energy, and
perhaps a cell dying from energetic failure would adopt a different morphology. Further
study into the function of metabolism on linker cell death is likely warranted.
Another interesting gene I identified is zfp-1. zfp-1 encodes a protein homologous
to human AF10, implicated in leukemia as a result of translocation with MLL [193].
ZFP-1 contains leucine zippers, zinc fingers, and PHD/LAP domain. In C. elegans, zfp-1
has been implicated as a common mediator of lifespan regulation through the insulin-
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signaling pathway and after dietary restriction [194]. In linker cell death, zfp-1 had a
weak defect upon knockdown, but zfp-1 synergistically enhanced the pqn-41(ns294)
defect. Since pqn-41(ns294) is not a complete null, it would be prudent to test whether
we also see enhancement in the newly generated pqn-41(ns807) allele, which removes
the entire 34 kb locus.
zfp-1(ok554) appeared to be a hypomorphic allele with respect to its linker
cell defect. When I generated the genetic double mutant between zfp-1(ok554) and
pqn-41(ns294), however, these animals had extreme developmental defects, including
defects in egg laying and tail development. The defect in tail development was so
severe that it precluded me from easily scoring the linker cell death phenotype. These
phenotypes suggest that zfp-1 and pqn-41 may be working in other parallel in other
cellular contexts as well.
I recovered two other proteins with polyglutamine (PQN) domains, pqn-85, a
gene implicated in DNA repair, and pqn-59, which is similar to the ubiquitin-associated
protein UBAP2. Both of these genes had weak RNAi phenotypes, but it may be
interesting to create a triple mutant between the three PQN genes to determine
how they influence each other. I find it intriguing that we have three putative genes
implicated in linker cell death that all contain polyglutamine repeats, especially given the
prevalence of these genes in neurodegenerative disorders.
The negative regulator of transcription, TAG-153, had a weak surviving linker cell
defect upon knockdown by RNAi. The loss-of-function allele, ok699, had no appreciable
defect, however. Interestingly, knocking down tag-153 in a pqn-41(ns294) background
suppressed the pqn-41 defects by half. To determine how these genes work together,
it would be prudent to create a double mutant allele between tag-153(ok699) and
pqn-41(ns294) or pqn-41(ns807) to see whether this suppression also occurs in the
genetic double mutants.
The best candidate I recovered and likely the gene that warrants the
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most attention is the homeodomain protein kinase hpk-1. Knockdown of hpk-1 in
pqn-41(ns294), egl-20(e585), and sek-1(ag1) animals suppressed their defects by
half. This result suggests that hpk-1 may function as an inhibitor of linker cell death,
downstream of these genes. hpk-1 RNAi in hsf-1(sy441) mutants did not affect the
number of SLCs, suggesting that hpk-1 may function upstream or in parallel to hsf-1.
Consistent with this, Jennifer Malin found that knockdown of hpk-1 in let-70(ns770)
animals also does not affect the let-70(ns770) defect [187].
Yeast lacking the hpk-1 homolog, Yak1, have a reduced resistance to heat
stress [195]. Yak1 phosphorylates Hsf1 in vitro, which enhances its DNA binding
ability [188]. These results support our finding that HSF-1-GFP fails to form stress
granules after heat shock when HPK-1 is missing. It should be noted that the result we
obtained is the opposite reported by [196], although they used knockdown of hpk-1 by
RNAi rather than a genetic mutant to examine this function.
HSF-1 in the linker cell can function in either a pro-survival, stress-related role
or a pro-death role [85]. The pro-death role of HSF-1 competes with its pro-survival
role at the start of linker cell death, likely through post-translational modifications. In
mammalian systems, sumoylation of HSF-1 inhibits its transcriptional activity [197], and
in C. elegans, HPK-1 antagonizes sumoylation of HSF-1 in order to positively modulate
its heat shock response [197]. One hypothesis we had from these results is that
because sumoylation of HSF-1 negatively affects its transcription of heat-shock-related
genes, then perhaps sumo-HSF-1 could have a distinct function in its cell death role.
Additional experiments are needed to test this hypothesis.
In C. elegans, HPK-1 promotes the pro-survival, stress-related role of HSF-1
during early larval stages [196,198], and perhaps likely also in the linker cell. In the
absence of HPK-1, the pro-survival function of HSF-1 is weakened, pushing the
system towards cell death. In fact, hpk-1(pk1393) animals are unable to mate, although
their spermatids are fully functional. Perhaps in these animals the linker cell is dying
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prematurely and affecting gonad fusion to the cloaca. This hypothesis could be easily
tested in the long-term imaging device recently developed by Wolfgang Keil in our lab
(see Chapter 3).
I first stumbled upon HPK-1 through a protein interaction screen of PQN-41C.
Knockdown of hpk-1 by RNAi in a pqn-41 loss-of-function background suppressed the
surviving linker cell defects in pqn-41 animals by half. When I made a double mutant
between hpk-1(pk1393) and pqn-41(ns294), however, the suppression was weaker. To
analyze these interactions further, it would be useful to determine if hpk-1(pk1393) is
able to suppress the defects seen in the complete null of pqn-41. If our model is correct
(Figure 2-7), knocking out hpk-1 in a complete null background of pqn-41 should reduce
the defects of pqn-41. Additionally, because pqn-41 is a cold-sensitive protein, and
hpk-1 plays a role in the heat shock response, it will be useful to determine how the
double mutant behaves at 15oC and at 25oC.
One model of how these proteins are working in the linker cell is that PQN-41C

Poly-Q
PQN-41

kinase

LC
HSF-1

HPK-1

HSF-1

Cell Death

HS
P

Cell Survival

Figure 2-7. Model for how PQN-41C, HPK-1, and HSF-1 function in linker cell
death.
PQN-41C acts upstream of HSF-1, likely promoting its cell death function. PQN41C interacts physically with HPK-1, perhaps inhibiting its pro-survival role of HSF-1
modulation after stress conditions.
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binds HPK-1 at the onset of linker cell death, inhibiting its pro-survival function towards
HSF-1 (Figure 2-7). One way to test this hypothesis is with an in vitro phosphorylation
assay. Incubating HPK-1 and HSF-1 together with radioactive phosphate may result
in some of the phospho-groups transferring to HSF-1. If we now add recombinant
PQN-41C to this reaction, perhaps phosphate is no longer incorporated. Given that
these proteins are relatively unstable, this hypothesis may be more difficult to test in
actuality, but it would be a worthwhile experiment.
In addition to the interplay between PQN-41C, HSF-1, and HPK-1, I also
observed some other interesting defects while trying to determine the function of hpk-1
in linker cell death. hpk-1(pk1393); sek-1(ag1) double mutants were synthetically lethal,
suggesting that these genes may function in parallel in vital cellular processes. I also
found that bar-1(ga80) hpk-1(pk1393) double mutants have a SLC defect of nearly
100%. bar-1(ga80) is not a complete null, making interpretation of this data difficult. In
Xenopus and Drosophila, however, HIPK1 can repress or activate β-catenin targets,
depending on the developmental context [199,200], suggesting that these genes
function together in other cellular systems. One hypothesis I had about their function
in the linker cell is that lacking both genes may alter the linker cell’s stress levels and
promote the stress-related function of HSF-1, independent of HPK-1. For example,
bar-1(ga80) animals fed empty vector control RNAi bacteria have linker cell defects of
91%, compared to 56% in bar-1(ga80) animals under normal, non-RNAi conditions. This
result suggests that bar-1 animals are ultrasensitive to perturbations in stress activation
(simply activating the RNAi pathway in this background is enough to nearly inhibit linker
cell death completely).
Another hypothesis is that HPK-1 phosphorylates BAR-1 and stabilizes it. In ga80
mutants, this stabilization is crucial for mutated BAR-1 to maintain some of its protein
levels and carry out partial wild-type function. In the absence of HPK-1, this stabilization
is lost, and bar-1(ga80) hpk-1(pk1393) double mutants could represent total BAR-1 loss
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with respect to its linker cell function. This hypothesis is derived from the fact that HIPK2
stabilizes β-catenin homologs in Xenopus [200], Drosophila [199] and in vitro [199].
The interplay between PQN-41, HPK-1, HSF-1, and BAR-1 represents an
exciting avenue of future research and may tell us more about the fine-tuning of linker
cell death onset.
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3. RAB-35 and ARF-6 GTPases mediate engulfment and clearance
following linker cell-type death
3.1. Summary
Following death, the linker cell must be engulfed and degraded. Therefore it is a
particularly attractive in vivo model for investigating the clearance of a cell that normally
dies non-apoptotically: the time of linker cell death onset is predictable, the process can
be followed in live animals, and engulfment events can be dissected genetically.
In this chapter, I show that engulfment and degradation of the linker cell
differs in mechanics and genetics from apoptotic cell clearance. I demonstrate that,
unlike apoptotic cell corpses, the linker cell is simultaneously engulfed by two U celldescendent phagocytes, resulting in cell splitting. Apoptotic engulfment genes are
not required for this novel form of engulfment. Rather, I find that the GTPase RAB-35
is a key coordinator of at least two steps in linker cell degradation. Early on, RAB35 localizes to extending phagocyte pseudopods, and prevents premature onset of
phagocytosis. Once engulfment has occurred, RAB-35 drives degradation of the linker
cell by promoting recruitment of RAB-5 and then RAB-7 GTPases onto phagosome
membranes, and subsequent lysosomal fusion and degradation. I demonstrate that
both activities of RAB-35 require inactivation of another conserved small GTPase,
ARF-6, which I show functions as a clearance inhibitor. RAB-35 physically interacts
with the ARF-6 GTPase activating protein CNT-1, providing a plausible mechanism for
ARF-6 inhibition. Furthermore, while RAB-35 localizes to engulfing-cell and phagosome
membranes during most of linker cell clearance, ARF-6 only transiently persists at the
membrane, and its timely removal depends on RAB-35.
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3.2. Linker cell corpse clearance occurs by a novel mechanism
3.2.1. The dying linker cell is simultaneously engulfed by two neighboring
cells
Linker cell death and clearance occurs during the transition from the fourth larval
stage to the adult, and can take up to 8 hours to complete [82,201]. To examine this
process at high spatiotemporal resolution, I used a long-term imaging microfluidic device
that Wolfgang Keil, a postdoc in the lab, previously developed [198] to simultaneously
image the linker cell (mig-24p::Venus) and the engulfing cells (lin-48p::mKate2) in live
animals (Figure 3-1). Animals were loaded into the device, and z-stacks were acquired
every 8 min for > 20h (Figure 3-1). Animal development and linker cell death kinetics
were not affected by either imaging or fluorescent reporter identity (Figure 3-1b, Table
3-1, top). The timings of characteristic events accompanying linker cell degradation

a mig-24p::Venus
lin-48p::mKate2

b

*

*

00h:00m

10h:00m

Figure 3-1. Microfluidic device for long-term imaging of linker cell death.
(a,b) C. elegans male immobilized in a microfluidic chamber (see [198]) at (a) first
contact between linker cell (green) and engulfing U.l/rp cell (magenta, asterisk), and (b)
after 10 hours. All males examined in all figures in Chapter 3 carry the male-producing
him-5(e1490) or him-8(e1489) mutation. Scale bar, 100 μm.
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Table 3-1. Reporter identity does not affect linker cell degradation
(mean ± SE of proportion).
% linker cell corpses
Genotype
N
in 24h adults
qIs56[LCp::GFP]
12 ± 3.2
100
nsIs65[LCp::Venus]
11 ± 3.1
100
nsIs60[LCp::Venus]
5 ± 2.1
103
arf-6(ns388); nsIs65
64 ± 4.8
101
rab-35(b1013); nsIs65
79 ± 4.0
102
nsIs589[UCp::mKate2]; nsIs65
5 ± 5.0
101
arf-6(ns388); nsIs589; nsIs65
57 ± 6.6
56
rab-35(b1013); nsIs589; nsIs65
54 ± 8.4
35
nsIs653[UCp::mKate2-PH]; nsIs65
1 ± 1.0
104
nsIs60; nsIs622[UCp::mCh-RAB-5]
0
100
nsIs592[UCp::mCh-RAB-7]; nsIs65
8 ± 2.8
91
nsIs586[UCp::CTNS-1-mKate2]; nsIs65
3 ± 1.7
101
nsIs650[LCp::mKate2]
4 ± 2.0
101
nsIs595[UCp::YFP-RAB-35]; nsIs650
2 ± 1.4
101
rab-35(b1013); nsIs595; nsIs650
1 ± 1.0
100
arf-6(tm1447); nsIs595; nsIs650
3 ± 1.7
101
nsIs625[UCp::ARF-6-YFP]; nsIs650
10 ± 3.9
59
arf-6(tm1447); nsIs625; nsIs650
4 ± 2.6
55
rab-35(b1013); nsIs625; nsIs650
51 ± 6.9
53
arf-6(tm1447); rab-35(b1013); nsIs625; nsIs650
43 ± 5.2
90
nsIs636[UCp::ARF-6 (D92N)-YFP]; nsIs650
56 ± 4.9
101
rab-35(b1013); nsIs713[UCp::YFP-RAB-35]; nsIs65 0
53
UCp = lin-48p; LCp = mig-24p, except for qIs56, which is lag-2p. All animals carried a
him-5(e1490) mutation in addition to the transgenes listed above.

were noted, with time zero corresponding to the time of first contact between the linker
cell and the U.lp or U.rp engulfing cells (Figure 3-2a), and are consistent with previous
reports [82,201].
I found that after first contact, the linker cell migrates so that it becomes
sandwiched between the U.lp and U.rp cells (Figure 3-2b), whose cell nuclei are
displaced anterior to the linker cell. Linker cell nuclear crenellation also becomes
apparent at this time (Figure 3-2c). Remarkably, following linker cell nuclear changes,
both U.l/rp cells simultaneously attempt to engulf the linker cell (Figure 3-2d,
Figure 3-3). During this process, which I term competitive phagocytosis, linker cell
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Figure 3-2. Linker cell death and degradation.
(a) Left: Maximum intensity projection showing linker cell at first contact with U.l/rp
cells. Right: 3D rendering. Scale bar, 10 μm. (b-j) Stereotypical events during linker cell
dismantling. Images as in (a), except that in (c,g,h) a single DIC slice is shown instead
of 3D rendering. Right, time of events in individual animals (blue circles) after first
contact. X, event did not occur during imaging. Bars, mean ± sd. Arrowhead, linker cell.
(b) Linker cell between U.l/rp cells (caret) (c) Nuclear crenellation onset. (d) Competitive
phagocytosis begins. (e) Linker cell rounding (f) Linker cell corpse splits. (g) Onset
of refractility. (h) End of refractility. (i) Small fragment disappears. (j) Large fragment
disappears.
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rounding (Figure 3-2e) is followed by splitting of the linker cell into two fragments
(Figure 3-2f). The larger linker cell remnant contains the nucleus, and is equally likely
to be found within U.lp or U.rp (8/19 and 11/19, respectively; p=0.5, χ2-test). The cell
engulfing the nucleus-containing fragment is more likely to be binucleate (17/19;
p=0.0006, χ2-test), a result of an earlier unrelated U cell descendent fusion event [202],
suggesting that the larger U.l/rp cell engulfs a larger portion of the linker cell. The larger
linker cell remnant, but not the smaller, then becomes refractile by DIC microscopy
(Figure 3-2g-h). The two linker cell fragments are degraded with similar kinetics
(Figure 3-2i-j). Competitive phagocytosis does not result in extensive leakage of linker
cell cytoplasm, as I never observed reporter protein outside the cell (N=35).
To identify the precise time point at which the linker cell fragments become
a mig-24p::Venus
lin-48p::mKate2

b

c

04h:08m

04h:16m

04h:24m

d

e

f

04h:40m

04h:56m

05h:12m

Figure 3-3. Competitive phagocytosis is dynamic.
Additional frames of animal shown in Figure 3-2, demonstrating back-and-forth tugging
events leading to linker cell splitting. Scale bar, 10 μm.
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internalized, I followed linker cell death in animals expressing the mKate2-PH reporter,
derived from PLC-δ1, which marks the plasma membrane and membranes of open
phagosomes by binding PI(4,5)P2 [203]. Localization of this reporter around the linker
cell ceases soon after cell splitting (Figure 3-4), suggesting that linker cell fragmentation
and U.l/rp internalization are coupled.
The unique mechanics governing linker cell dismantling raise the question of
whether U cell descendants are specifically equipped for linker cell clearance. To test
this, I examined animals carrying a mutation in the gene him-4, in which linker cell
migration is defective, and the cell ends up near the head [82]. In these animals, linker
cell death occurs fairly reliably, as determined by onset of nuclear crenellation [82].
However, while engulfment and degradation by neighboring cells can occur, it is
inefficient (62 ± 6.9% remaining corpses in 24h adult males, N=50, p<0.0001 compared
to wild type, Fisher’s exact test). Thus, U.l/rp cells exhibit specialization for linker cell
clearance.
a mig-24p::Venus
lin-48p::mKate2-PH

left b

right

left c

right

left d

left

right

right
vac

02h:40m
3D rendering

03h:52m

04h:00m

04h:32m

Figure 3-4. mKate2-PH is removed from the plasma membrane immediately after
splitting, indicating internalization.
Linker cell splitting correlates with loss of mKate2-PH, an open phagosome marker.

Scale bar, 10 μm. (a-b) Arrowhead, mKate2-PH plasma membrane marker around linker
cell prior to cell splitting (c-d) Caret, mKate2-PH plasma membrane marker absent from
phagosome after cell splitting.
57

3.2.2. Apoptotic engulfment genes are not required for linker cell clearance
It was previously reported that linker cell engulfment can occur in animals
lacking apoptosis engulfment genes [82]; however, whether the cell is eventually
degraded in these settings was not examined. To look at this in detail, I followed linker
cell engulfment in animals lacking components of each or both parallel pathways that
together drive apoptotic cell engulfment. Animals were scored 24h after the L4-to-adult
transition, when the majority of animals have cleared the linker cell corpse [201]. I
found that linker cell engulfment is only weakly perturbed by mutations in some known
engulfment genes (Table 3-2). Furthermore, double mutants between engulfment
genes in different pathways do not strongly affect linker cell clearance. Consistent
with this observation, when I expressed MFG-E8-GFP, a phosphatidylserine binding
protein [204,205], in U cell descendants, I did not observe fluorescence accumulation
around the linker cell (5 lines, >100 animals scored in total). Nonetheless, I did find that
mutations in the phagosome maturation gene sand-1 significantly inhibit clearance of
linker cell debris (Table 3-2).
Thus, while genes promoting cell corpse degradation following engulfment
are shared between linker cell death and apoptosis, upstream genes required for
phagocytosis and the initiation of degradation are different. Linker-cell-specific
engulfment genes remain, therefore, to be discovered.
3.3. A forward genetic screen to identify new factors in engulfment and
clearance
To identify components of the linker cell engulfment machinery, I sought
mutants in which linker cell engulfment and/or degradation are defective. To do so,
I mutagenized hermaphrodites carrying a lag-2p::GFP linker cell reporter and a
him-5 mutation, which increases the proportion of male progeny (Figure 3-5a). After
two generations, males were screened for linker cell persistence. It was previously
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Table 3-2. Canonical apoptotic engulfment genes play a minor role in linker cell
corpse removal
(mean ± SE of proportion).
% linker cell corpses
Genotype
Mammalian homolog
N
in 24h adults
WT
12 ± 3.2
100
ced-1(e1735)
CD91
14 ± 3.4
103
ced-6(n2095)a
Gulp
9 ± 2.9
100
ced-7(n1892)
ABCA
7 ± 2.3
120
ced-2(e1752) a
CrkII
20 ± 4.0*
102
ced-5(n1812) a
Dock180
12 ± 2.9
125
ced-12(k149)
Elmo
27 ± 4.5*
96
ced-10(n1993)
Rac1
26 ± 4.5*
97
ced-1; ced-5
21 ± 3.2
162
ced-7; ced-10
27 ± 4.5*
98
nuc-1(e1392)
DNaseII
31 ± 4.5**
104
cep-1(gk138)
p53
12 ± 3.2
103
ced-8(n1891)
XK
7 ± 2.5
104
dyn-1(ky51)
dynamin
22 ± 4.1
103
ttr-52(tm2003)
transthyretin-like
7 ± 2.5
101
ttr-52(tm2078)
transthyretin-like
4 ± 1.9
102
psr-1(ok714)
phosphatidylserine receptor 7 ± 2.5
103
psr-1(tm469)
phosphatidylserine receptor 4 ± 2.6
56
piki-1(ok2346)
PI3K
13 ± 3.4
94
unc-108(n3263)
Rab2
5 ± 2.3
88
sand-1(or552)
Mon1
38 ± 4.9***
97
sand-1(ok1963)
Mon1
58 ± 4.8***
104
b
rme-1(b1045)
EHD4
19 ± 6.1
42
scav-1(ok2598)
Scarb1
12 ± 5.1
41
scav-2(ok877)
CD36
4 ± 2.7
54
scav-3(ok1286)
CD36
3 ± 2.1
64
scav-5(ok1606)
Scarb1
5 ± 2.9
56
cdh-3(gk178860)
cadherin
13 ± 4.5
56
cdh-3(pk87)
cadherin
3 ± 2.8
36
a
b
nsIs1[lag-2p::GFP, rol-6(+)]; nsIs65[mig-24p::Venus]; him-8; *: p < 0.05, Fisher’s exact
test; **: p < 0.005, Fisher’s exact test; ***: p < 0.0001, Fisher’s exact test. All animals
carried a him-5(e1490) mutation and qIs56[lag-2p::GFP] linker cell marker, unless
otherwise noted.
shown that animals defective in linker cell death exhibit gonadal blockage, and can be
sterile [82]. I therefore directly collected spermatids from mutant males by impaling a
needle into the gonad, and used these spermatids to artificially inseminate wild-type
hermaphrodites [206] (Figure 3-5b-d, see Methods for details). Cross progeny were then
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Supplementary Figure 2.
a

Mutagenize synchronized
L4 lag-2p::GFP; him-5

EMS

b male

c hermaphrodite

collect F2 males with
persistent LC corpse

collect spermatids and
artificially inseminate
WT hermaphrodites
d hermaphrodite
identify GFP+ cross progeny

generate homozygous
mutant strains
and verify phenotype

Figure 3-5. Genetic screen for linker cell degradation mutants.
(a) Genetic screen scheme. (b-d) Artificial insemination procedure. (b) Needle filled with
buffer plunged into a 24h mutant adult male gonadal cavity. Spermatids automatically
flow into the needle (arrow). (c) Needle aligned with a wild type hermaphrodite vulva
(arrowhead). (d) Needle inserted into the vulva and spermatids released. Released
spermatids fill the hermaphrodite gonadal cavity (arrows).

used to establish mutant lines.
I screened 15000 genomes, and isolated 181 males for artificial insemination.
From these, I had 66 successful inseminations (36% success rate), and obtained
59 mutants lines (some of the successful inseminations only produced male crossprogeny). 44 of these strains were confirmed under the compound microscope, as
having some defect in linker cell death or degradation, while the rest were considered to
be false positives (Appendix).
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I divided each of the remaining strains into five categories: I. weakly surviving,
II. relatively healthy, III. odd death, IV. delayed death, and V. persistent corpse (see
Appendix for descriptions of classifications and phenotype analysis of the remaining
mutants). For my thesis work, I focused on the three strongest mutants in the class V,
and the subsequent analyses are described in this chapter.
3.4. RAB-35 pathway
3.4.1. RME-4/DENND1 promotes linker cell engulfment and degradation
One mutant, ns410, exhibits persistent refractile linker cell corpses, and was
further studied (Figure 3-6a). Using standard genetic mapping, coupled with whole
genome sequencing, I identified a mutation predicted to generate a G100E alteration

DIC

n.s.
p<0.0001
p<0.0001

b

%24h adults with linker cell corpse

a rme-4(ns410)

p<0.0001

60

24h post molt
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0

100
WT

91
-

286

337

306

+rme-4 +UCp:: +LCp::
fosmid rme-4A rme-4A
rme-4(ns410)

Figure 3-6. ns410 is a mutation in rme-4.
(a) DIC image of persistent linker cell corpse (arrowhead) in rme-4(ns410). Scale bar,
10 μm. (b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP
linker cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals
scored inside bars. Average of at least three independent lines. Error bars, standard
error of the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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uDENN
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dDENN
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rme-4A

ns410

ns412
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G100E

S217N

G257D

rme-4B
tm1865

Figure 3-7. rme-4 gene locus.
Pink diamonds, locations of point mutations. Yellow box, deletion allele tm1865.
in the DENN domain protein RME-4, homologous to vertebrate DENND1 [204]
(Figure 3-7). Linker cell degradation is restored to ns410 mutants by expressing a
fosmid spanning the genomic region of rme-4 (Figure 3-6b). Furthermore, two other
rme-4 alleles, ns412 (S217N; isolated in my screen) and b1001 (G257D; a previously
characterized loss-of-function lesion [207]) also promote linker cell degradation defects,
as does the rme-4(tm1865) deletion allele (Figure 3-8). rme-4(tm1865) mutants exhibit
a weaker linker cell survival defect, perhaps because the truncated RME-4 protein

%24h adults with linker cell corpse

produced in this mutant is present at half wild-type levels [204]. RNAi against rme-4

p=0.0051
p=0.0005
p<0.0001
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p<0.0001
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rme-4 +UCp:: rme-4 +rme-4 rme-4 rme-4 tm1865
(ns410) rme-4B (ns412) fosmid (b1001) (tm1865) +rme-4
RNAi

Figure 3-8. Phenotypic analysis of other mutations in rme-4.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored
inside bars. Average of at least three independent lines. Error bars, standard error of the
proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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exacerbates the defect of animals carrying this allele (Figure 3-8). Taken together, these
results demonstrate that the rme-4 gene is required for linker cell corpse degradation.
RME-4 is widely expressed and found in the linker cell and in its engulfing cells
(Figure 3-9). To determine where RME-4 functions, I expressed cDNAs for either the
rme-4A or rme-4B transcript (Figure 3-7) in either the linker cell or the engulfing cells.
I found that the longer A isoform restores linker cell degradation when expressed in
U cell descendants, but not when expressed in the linker cell (Figure 3-6). B isoform
expression in the engulfing cells has no effect (Figure 3-8). Thus, RME-4A is the active
isoform driving linker cell engulfment, and it does so by acting in the engulfing cells.
3.4.2. RAB-35 GTPase Is a key linker cell degradation regulator controlled
by RME-4/DENND1 and TBC-10/TBC1D10A
The RME-4 DENN domain was previously proposed to drive the guanine
nucleotide exchange reaction (GEF function) of the small GTPase RAB-35 [207,208].
The ns410, ns412, and b1001 rme-4 alleles are predicted to cause single amino-acid
changes within this domain, suggesting that RME-4 could function as GEF during
linker cell degradation. To test this directly, I examined two rab-35 mutants, tm2058 and

rme-4p::rme-4A-GFP

DIC

Figure 3-9. rme-4 translational reporter expression.
Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP. Bottom: DIC. Scale bar, 10 μm.
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b1013, that carry a small deletion surrounding the start codon, and an early Q69Ochre
stop mutation, respectively (Figure 3-10a). I found that both lesions inhibit linker cell
corpse degradation, and persistent corpses resemble those seen in rme-4 mutants
(Figure 3-10b,c). While rab-35 is broadly expressed (Figure 3-11), I found that linker cell
degradation is restored to rab-35 mutants by expression of rab-35 cDNA in engulfing
cells, but not in the linker cell (Figure 3-10b). Thus, RAB-35 is required in engulfing cells
0.5 kb
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rab-35
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[GDP]
S24N
80

Q69stop Q69L
p<0.0001
n.s.
p<0.0001

c rab-35(b1013)

%24h adults with linker cell corpse
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24h post molt

40

20

0

99

rab-35
(tm2058)

105
-

313
311
510
301
+UCp:: +LCp:: +UCp:: +UCp::
rab-35 rab-35 rab-35 rab-35
[GTP] [GDP]
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Figure 3-10. Mutations in rab-35 cause a persistent corpse defect.
(a) rab-35 gene locus. Yellow box, deletion allele tm2058. Pink diamonds, point
mutations. Red octagon, early stop allele b1013. (b) Linker cell degradation in indicated
genotypes. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). UCp,
lin-48p. LCp, mig-24p. Number of animals scored inside bars. Average of at least three
independent lines. Error bars, standard error of the proportion or standard error of the
mean. n.s., p>0.05, Fisher’s exact test. (c) DIC image of persistent linker cell corpse
(arrowhead) in rab-35(b1013).
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rab-35p::GFP-rab-35

DIC

Figure 3-11. rab-35 translational reporter expression.
Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP. Bottom: DIC. Scale bar, 10 μm.

for linker cell degradation.
RAB-35 and other small GTPases cycle between GTP and GDP bound forms.
If RME-4 functions as a RAB-35 GEF, I expect RAB-35[GTP] to be the active form of
the protein in linker cell degradation. Indeed, I found that expression of RAB-35(Q69L),
predicted to lock the protein in the GTP-bound configuration, fully restores linker
cell degradation to rab-35(b1013) mutants (Figure 3-10b). A GDP-bound mimetic,
RAB-35(S24N), however, only partially rescues rab-35(b1013) linker cell defects.
Furthermore, I found that RAB-35(S24N) protein selectively binds RME-4A (but not
RME-4B) in a yeast two-hybrid assay [204] (Figure 3-12). Thus, RAB-35 functions with
RME-4 in engulfing cells, and RAB-35[GTP] is likely the relevant active form driving
linker cell clearance.
I next sought to identify the GTPase activating protein (GAP) completing the
RAB-35 GTPase cycle. I reasoned as follows: weak RME-4 (GEF) mutations should
result in some RAB-35[GTP] production, but perhaps not enough for efficient linker cell
degradation. Combining an rme-4(weak) mutation with a RAB-35 GAP mutation, which
would block RAB-35[GTP] hydrolysis, could, however, allow sufficient accumulation of
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GDP
RAB-35
RAB-35
RAB-35
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RME-4A
RME-4B
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-His

Figure 3-12. RAB-35[GDP] interacts with RME-4A.
Yeast two-hybrid assay with LexA-RAB-35[S24N] (GDP) as bait, and Gal4-AD (GAD)
empty vector, GAD-RME-4A, or GAD-RME-4B as prey. Top: histidine present. Bottom:
histidine absent. Growth on -His plates, physical interaction.

RAB-35[GTP] for efficient linker cell degradation. I therefore screened for the effects of
mutations in C. elegans homologs of the known mammalian Rab35 GAP genes tbc-7/
Tbc1D24, tbc-10/Tbc1D10A, and tbc-13/Tbc1D13 [209]. Mutations or knockdown of
these genes alone have no effect on linker cell corpse degradation, nor do they rescue
linker cell degradation defects of animals carrying the strong rme-4(ns410) mutation, in
which no RAB-35[GTP] is predicted to accumulate (Figure 3-13a). However, combining
the tbc-10(gk388086) allele with the weak rme-4(tm1865) allele restores normal linker
cell degradation (Figure 3-13b). Thus, TBC-10 is likely the RAB-35 GAP.
Supporting this notion, while TBC-10 protein is widely expressed
(Figure 3-13c), specific expression of TBC-10 in U cell descendants of rme-4(tm1865);
tbc-10(gk388086) double mutants reintroduces the linker cell degradation defect. Similar
expression of a TBC-10(R225A) protein, containing a lesion in the putative catalytic
arginine finger, has no effect (Figure 3-13b).
Taken together, these results suggest that RAB-35[GTP] is a key regulator of
linker cell degradation, and that its activity is controlled by RME-4/GEF and TBC-10/
GAP.

66

% 24h adults with linker cell corpse

a
80

p=0.08

60

n.s.

40
20
0

100
WT

100
tbc-7
RNAi

103
tbc-10

119
tbc-13

91
-

% 24h adults with linker cell corpse

b

97
-

101
108
tbc-7 tbc-13
RNAi
+rme-4(tm1865)

c tbc-10p::GFP

n.s.
p<0.0001

60

p<0.0001

40
n.s.

20
0

42
106
106
tbc-7 tbc-10 tbc-13
RNAi
+rme-4(ns410)

100
WT

DIC

319
97
108
+UCp:: rme-4
tbc-10 (tm1865)

311
304
+UCp:: +UCp::
tbc-10 tbc-10
(R225A)

tbc-10(0); rme-4(lf)

Figure 3-13. TBC-10 is the putative RAB-35 GAP in linker cell corpse removal.
(a,b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored
inside bars. Average of at least three independent lines. Error bars, standard error of
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (c) tbc-10
transcriptional reporter. Arrowhead, linker cell. Caret, U.l/rp cells. Top: GFP. Bottom:
DIC. Scale bar, 10 μm.
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3.4.3. RAB-35 promotes timely onset of linker cell engulfment and is
required for subsequent phagosome maturation
To define more specifically the defects associated with loss of RAB-35, I imaged
rab-35(b1013) mutants using the microfluidic setup, and quantified hallmark linker cell
death and degradation events over > 24h (Table 3-1). I found no significant differences
compared to wild-type animals in the onset or duration of developmental milestones
(e.g. tail-tip retraction or appearance of rays; Figure 3-14a-c), or in appearance of linker
cell death hallmarks (e.g. nuclear crenellation; Figure 3-14d-i). However, competitive
phagocytosis of the linker cell begins prematurely in rab-35 mutants (Figure 3-15a),
initiating before the linker cell has the opportunity to intercalate between the U.l/rp
cells (Figure 3-15b). While subsequent linker cell splitting occurs at the same time as
in wild-type animals (Figure 3-14g), formation of the larger refractile corpse is delayed
(Figure 3-15c), and refractility can last much longer (Figure 3-15d). Mutations in rab-35
delay degradation of the large fragment, if it occurs at all (Figure 3-15e,f). The smaller
linker cell fragment is degraded as in the wild type (Figure 3-14h). Thus, RAB-35 plays
roles in both engulfment initiation and phagosome maturation.
Consistent with a role in engulfment initiation, I found that RAB-35, tagged with
the fluorescent reporter YFP, localizes to extending pseudopods early on, and remains
enriched around the larger linker cell-containing phagosome for an extended period of
time, until late stages of linker cell degradation (Figure 3-16).
Some aspects of phagosome maturation have been previously characterized.
I therefore sought to address where in this process RAB-35 functions. To do so, I first
generated animals expressing both YFP-RAB-35 and either mCherry-RAB-5, marking
early phagosomes, mCherry-RAB-7, marking late phagosomes, or CTNS-1-mKate2,
marking the phagolysosome (Table 3-1). In wild-type animals, RAB-35 and RAB5 transiently co-localized on the phagosome membrane in 5/6 animals examined
(Figure 3-17a-d). In three of six animals, RAB-5 enrichment was seen in only a single
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Figure 3-14. Characterization of stereotypical events during linker cell clearance in
rab-35 and arf-6 mutants.
(a-i) Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter
[lin-48p::mKate2], him-5(e1490). Dots, individual events in single animals in hours with
respect to first contact. X, event did not occur; not factored into statistical analysis. Bars,
mean ± std. n.s., p>0.05, Student’s t-test.
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Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter
[lin-48p::mKate2], him-5(e1490). (a) Competitive phagocytosis onset in individual
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70

a YFP-RAB-35

b

c

01h:36m

04h:48m

06h:40m

YFP-RAB-35
linker cell

Figure 3-16. RAB-35 localizes to extending pseudopods and remains around the
phagosome.
Top: Localization of YFP-RAB-35 within U.l/rp cells. Bottom: YFP-RAB-35 (green), and
linker cell (mig-24p::mKate2; magenta). Scale bar, 5 μm.

frame over a 20h experiment (images acquired every 8 min), suggesting that RAB-5 can
move quickly on and off the phagosome membrane. RAB-7 and RAB-35 co-localization
is more sustained (Figure 3-18a-d, 7/7 animals). Furthermore, as RAB-35 disappears
from the phagosome membrane, mCherry-RAB-7 fluorescence accumulates within the
phagosome (Figure 3-18c,d). Such internalization of RAB-7 had not been previously
reported in other settings. CTNS-1 and RAB-35 exhibit minimal co-localization
(Figure 3-19), suggesting that RAB-35 is removed from the phagosome membrane once
lysosomal fusion occurs.
I next examined reporter localization in rab-35(b1013) mutants. I found that
RAB-5 fails to localize to the phagosome membrane in these animals (Figure 3-17e-g,
5/7 animals). Similarly, RAB-7 does not accumulate on the phagosome surface, and is
not taken up into the phagosome (Figure 3-18e-g, 5/5 animals).
These studies, therefore, support the idea that RAB-35 acts early in phagosome
maturation, and is required for recruiting RAB-5 and RAB-7 for proper degradation to
ensue.
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Figure 3-17. RAB-5 and RAB-35 transiently colocalize around the phagosome.
(a-d) Localization of YFP-RAB-35 (top) and mCherry-RAB-5 (middle) within the U.l/rp
cells examined during linker cell (LC) death and degradation in the wild type. Linker cell
not fluorescently labeled. Caret, site of colocalization. LC, linker cell. (e-g) mCh-RAB-5
imaged in a rab-35(b1013) animal (top). Bottom: mCh-RAB-5 overlaid on DIC image.
Arrowhead, linker cell. Scale bar, 5 μm.
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Figure 3-18. RAB-7 and RAB-35 colocalize around the phagolysosome.
(a-d) Localization of YFP-RAB-35 (top) and mCherry-RAB-7 (middle) within the U.l/rp
cells examined during linker cell (LC) death and degradation in the wild type. Linker
cell not fluorescently labeled. Caret, site of colocalization. LC, linker cell. Asterisk,
accumulation within phagosome. (e-g) mCherry-RAB-7 (top) fails to surround linker cell
in rab-35(b1013) mutant. Linker cell labeled in green. Scale bar, 5 μm.
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Figure 3-19. CTNS-1 and RAB-35 have
different localization patterns.
(a-c) Localization of YFP-RAB-35 (top)
and CTNS-1-mKate2 (middle) within the
U.l/rp cells examined during linker cell
(LC) death and degradation in the wild
type. Bottom: merge, YFP-RAB-35, green;
CTNS-mKate2, magenta. Scale bar, 5 μm.
Caret, minimal colocalization between
RAB-35 and CTNS-1.
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3.5. ARF-6 pathway
3.5.1. The small GTPase ARF-6 blocks linker cell clearance
To delineate the molecular mechanism by which RAB-35 controls linker cell
engulfment onset and degradation, I pursued studies of another mutant, ns388, isolated
in the genetic screen. Animals carrying this lesion have similar linker cell defects to
rab-35 mutants (Figure 3-20a,b), but do not harbor mutations in rab-35, tbc-10, or
rme-4.
Using whole genome sequencing and standard genetic mapping, I found that
ns388 animals contain a point mutation predicted to cause a D92N mutation in the
small GTPase ARF-6 (Figure 3-21). Importantly, and unlike rab-35 mutations, a single
arf-6(ns388) allele is sufficient to block linker cell degradation. Thus, arf-6(ns388)
is a dominant allele. The arf-6(tm1447) putative null allele, which lacks most of the
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Figure 3-20. ns388 is a dominant allele of arf-6.
(a) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored
inside bars. Average of at least three independent lines. Error bars, standard error of the
proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (b) DIC image
of persistent linker cell corpse (arrowhead) in arf-6(ns388) male. Scale bar, 5 μm.
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Figure 3-21. arf-6 genomic locus and mutant location.
Yellow box, deletion alleles. Caret, single nucleotide insertion allele ns764. Pink
diamonds, point mutations.

coding region, and has no ARF-6 expression by Western blot[207], exhibits normal
linker cell clearance (Figure 3-20a, 3-21), suggesting that arf-6(ns388) is a gain-offunction and not a dominant-negative allele. To confirm that arf-6 is indeed the relevant
gene, I generated two independent CRISPR alleles, ns751 and ns752, recreating the
arf-6(ns388) lesion. Both promote linker cell defects similar to those of arf-6(ns388)
mutants (Figure 3-22). Furthermore, while arf-6 is widely expressed (Figure 3-23),

% 24h adults with linker cell corpse

60

*

*

*

40

n.s.

n.s.

n.s.

20

0

100
WT

107 105
ns751ns752
[D92N]

104
107 102
ns760 ns761 ns762
[T44N]

100 102
ns765 ns771
[Q67L]

101
ns763
[I42M;
P43T]

105 102 101 101
ns753 ns764 ns767 ns769
[putative nulls]

Figure 3-22. CRISPR generated alleles of arf-6.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard
error of the proportion. n.s., p>0.05; *, p<0.05; Fisher’s exact test.
75

a arf-6p::arf-6-GFP

b arf-6p::arf-6(ns388)-GFP

Figure 3-23. Wild-type arf-6 and arf-6(ns388) are broadly expressed.
(a,b) Arrowhead, linker cell. Caret, U.lp or U.rp cell. Top: GFP; bottom: DIC. Scale bar,
10 μm. (a) arf-6 translational reporter expression. (b) arf-6(ns388) translational reporter
expression.

expression of an arf-6(ns388) cDNA in engulfing cells blocks linker cell clearance
(Figure 3-20a). Wild-type arf-6 expression in engulfing cells does not affect linker cell
death, nor does expression of either arf-6(ns388) or arf-6(+) cDNAs in the linker cell
(Figure 3-20a).
These results, therefore demonstrate that gain of ARF-6 function blocks linker
cell clearance, and suggest that ARF-6 normally functions as a linker cell clearance
inhibitor.
3.5.2. ARF-6(gf) promotes premature competitive phagocytosis onset and
delays linker cell degradation
To understand how ARF-6(gf) interferes with linker cell clearance, I imaged
arf-6(ns388) animals in the microfluidic device and followed hallmark linker cell death
and degradation events (Table 3-1). Except for a slight advance in cuticle shedding,
no defects in animal development or linker cell killing are seen in arf-6(ns388) mutants
(Figure 3-14). However, as with rab-35 mutants, premature onset of competitive
phagocytosis is observed (Figure 3-24a,b), formation of a refractile linker cell
corpse is delayed (Figure 3-24c), and the period of linker cell refractility is prolonged
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Figure 3-24. arf-6(gf) causes premature competitive phagocytosis and delays large
fragment degradation.
(a) Arrowheads, premature competitive phagocytosis in arf-6(ns388). Scale bar, 10 μm.
(b-e) Quantification of linker cell clearance events in arf-6(ns388). Strains contain linker
cell reporter [mig-24p::Venus], U.l/rp cell reporter [lin-48p::mKate2], him-5(e1490). Bars,
mean ± sd. Student’s t-test. WT, wild-type. X, Event persisting or not observed by end of
imaging; not included in statistical analysis.

(Figure 3-24d). Degradation of the large linker cell fragment is greatly delayed, if it
occurs at all (Figure 3-24e).
The similar defects exhibited by arf-6(ns388) and rab-35 mutants suggests that
the proteins encoded by these genes may localize in a similar manner. To test this
idea, I expressed ARF-6-YFP in the U.l/rp cells and followed its localization changes
during linker cell death and degradation (Figure 3-25a-c). ARF-6-YFP localizes to
U.l/rp pseudopods (Figure 3-25a), remains enriched on the phagosome membrane
after cell splitting (Figure 3-25b), and then rapidly translocates to intracellular puncta
(Figure 3-25c). Importantly, enrichment of mCherry-RAB-5 around the phagosome
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Figure 3-25. ARF-6-YFP localizes to extending pseudopods, the nascent
phagosome, and then translocates to intracellular puncta before RAB-5
enrichment.
(a-c) Top: Localization of ARF-6-YFP within the U.l/rp cells. Caret, ARF-6 on phagosome
membrane. Arrowhead, ARF-6 in intracellular puncta. Bottom: ARF-6-YFP (green),
and linker cell (mig-24p::mKate2; magenta). (d-g) Localization of ARF-6-YFP (top)
and mCherry-RAB-5 (middle). LC, linker cell. Asterisk, accumulation of RAB-5 within
phagosome. Scale bar, 5 μm.

occurs after ARF-6-YFP removal (Figure 3-25d-g, 5/6 animals). As with RAB-7, I also
observed RAB-5 accumulation in the phagosome interior (Figure 3-25g, 6/6 animals).
Thus, ARF-6 and RAB-35 localize to similar structures surrounding the dying
linker cell. However, while RAB-35 normally promotes linker cell degradation, ARF-6
blocks this process.
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3.5.3. ARF-6 function is regulated by CNT-1/ACAP2 and EFA-6/EFA6
To understand the dominant nature of the ARF-6(D92N) lesion, I attempted
to assess the consequences of locking ARF-6 protein in the GTP or GDP bound
states [211]. I used CRISPR to generate arf-6 mutants encoding T44N and Q67L
mutations (Figure 3-22), predicted to accumulate ARF-6[GDP] or ARF-6[GTP] proteins,
respectively. Neither mutant, however, has linker cell defects, perhaps because they
destabilize the protein. Consistent with this interpretation, the arf-6(Q67L) allele
behaves as a null in genetic assays (see below). I did however, serendipitously isolate
from the CRISPR mutagenesis an arf-6(I42M;P43T) double mutant with linker cell
clearance defects. Based on an Arf6:Arf6GAP co-crystal protein structure [212], these
lesions may interfere with GAP binding to ARF-6, and subsequent GTP hydrolysis.
D92 of Arf6 forms intramolecular hydrogen bonds with R95 (Figure 3-26a). In the D92N
mutant, these hydrogen bonds are lost (Figure 3-26b), which may result in loss of
stability of adjacent interactions. Both P43 and I42 of Arf6 form hydrophobic interactions
with W451 and I462 on the ArfGAP (Figure 3-26c). These interactions are lost in
the P43T;I42M mutations (Figure 3-26d). Therefore, ARF-6[GTP] appears to inhibit
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Figure 3-26. Mutations in ARF-6 are predicted to disrupt ArfGAP binding.
(a) Protein structures of human Arf6 (teal) and ArfGAP (blue) from [209]. PDB: 3LVQ.
Relevant amino acids indicated in white. Yellow dotted line, hydrogen bonds. White
ladder, hydrophobic interactions. Amino acids shown are conserved in C. elegans
ARF-6 and CNT-1. (b) D92N mutation mapped onto Arf6. Protein structure information
as in (a). (c) Different region of Arf6 and ArfGAP. Protein structure information as in (a).
(d) I42M, P43T mutations mapped onto Arf6.
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phagosome maturation during linker cell clearance, and the mutants I isolated may
hinder GAP binding.
To test this idea further, I reasoned that mutations in a relevant ARF-6 GAP
would exhibit linker cell clearance defects, as they would lock ARF-6 in the GTP-bound
state. From a screen of candidate mutations (Figure 3-27a, Table 3-3), we found that
two independent putative null alleles of cnt-1, encoding a ubiquitously-expressed

p<0.0001
p<0.0001
p<0.0001

60

b
p<0.0001

40
20
0

100
WT

101
101
102
103
cnt-1 gk899634; cnt-1 tm2313;
(gk899634) arf-6(0) (tm2313) arf-6(0)

c CNT-1A CNT-1B CNT-1A CNT-1B CNT-1A CNT-1B
ARF-6 ARF-6 ARF-6 ARF-6 ARF-6 ARF-6
(D92N) (D92N) (I42M; (I42M;
P43T) P43T)

% 24h adults with linker cell corpse

80

% 24h adults with linker cell corpse

a

60

n.s.
n.s.
p<0.0001

40
20
0

101
-

306
312
303
+UCp:: +UCp:: +LCp::
cnt-1A cnt-1A cnt-1A
(R490A)
cnt-1(gk899634)

+His
-His

Figure 3-27. CNT-1A is the relevant ARF-6 GTPase activating protein (GAP).
(a,b) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker
cell reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored
inside bars. Average of at least three independent lines. Error bars, standard error of
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test. (c) Yeast
two-hybrid assay with LexA-CNT-1A or LexA-CNT-1B as bait, GAD-ARF-6, GAD-ARF6(D92N) or GAD-ARF-6(I42M,P43T) as prey. Top: histidine present. Bottom: histidine
absence. Growth on -His plates indicates physical interaction.
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Table 3-3. Other putative ARF-6 GAPs have no linker cell defect
(mean ± SE of proportion).
% linker cell corpses
Genotype
N
homolog
in 24h adults
WT
12 ± 3.2
100
F23H11.4(gk585084)
8 ± 4.3
39
ARAP1-3/ ArfGAP
F23H11.4(gk165637)
13 ± 3.4
96
ARAP1-3/ ArfGAP
git-1(ok1848)
10 ± 3.9
59
GIT1
git-1(gk392605)
15 ± 5.6
41
GIT1
gap-2(ok1001)
10 ± 4.2
52
SynGAP/RasGAP
cnt-2(gm377)
12 ± 3.2
102
ArfGAP
All animals carried a him-5(e1490) mutation and qIs56[lag-2p::GFP] linker cell marker.

protein similar to vertebrate Acap2, block linker cell clearance (Figure 3-27a, 3-28a,b).
Expression of the CNT-1A isoform in U.l/rp cells, but not the linker cell, fully rescues
linker cell defects of cnt-1 mutants (Figure 3-27b); whereas CNT-1B expression gives
partial rescue (Figure 3-28c). Rescue is abolished by mutating the catalytic arginine
of CNT-1A (Figure 3-27b). Importantly, ARF-6 is required for the linker cell defects
of cnt-1 mutants, as an arf-6(tm1447) loss-of-function mutation restores linker cell
clearance to cnt-1 mutants (Figure 3-27a). Consistent with the idea that the D92N and
I42M;P43T mutations disrupt GAP binding, I found that while wild-type ARF-6 interacts
with CNT-1A (but not CNT-1B) in a yeast two-hybrid assay; both ARF-6(D92N) and
ARF-6(I42M;P43T) fail to interact with CNT-1A (Figure 3-27c). Thus, ARF-6[GTP] is
likely the active form of the protein blocking linker cell removal, and CNT-1 is the ARF-6
GAP for linker cell clearance.
Similar reasoning used to identify TBC-10 as a RAB-35 GAP allowed me
to identify EFA-6, homologous to the mammalian Arf6 GEF Efa6 [210], as the
putative ARF-6 GEF for linker cell clearance. While the efa-6(ok3533) deletion allele
has no linker cell degradation defect, this allele restores linker cell clearance to
mutants carrying null alleles of cnt-1 (Figure 3-29a; cnt-1(tm2313); efa-6(ok3533):
14 ± 3.4%, N = 102, p<0.0001 compared to cnt-1(tm2313), Fisher’s exact test).
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Figure 3-28. cnt-1 is ubiquitously expressed, and CNT-1B is not involved in linker

cell corpse removal.
(a,b) cnt-1 transcriptional reporter expression. Caret, U.lp or U.rp cell. Arrowhead, linker
cell. Top: GFP; bottom: DIC. Scale bar, 10 μm. (c) Linker cell degradation in indicated
genotypes. Strains contain lag-2p::GFP linker cell reporter and him-5(e1490). UCp,
lin-48p. LCp, mig-24p. Number of animals scored inside bars. Average of at least
three independent lines. Error bars, standard error of the proportion or standard error
of the mean. n.s., p>0.05, Fisher’s exact test. #, significantly different from both cnt1(gk899634) and wild type. ^, only two lines out of three show significant rescue.

Furthermore, efa-6(ok3533) also blocks the dominant defects of arf-6(ns388)
and arf-6(ns763[I42M;P43T]) mutants, strengthening our assessment that
ARF-6 GTP loading is required for the function of these ARF-6 gain-of-function
proteins (Figure 3-29a,c). While EFA-6 is expressed in the linker cell and U.l/rp cells
(Figure 3-29b), expression of EFA-6 isoforms in the U.l/rp cells partially restores linker
cell clearance defects to efa-6(ok3533); arf-6(ns388) double mutants (Figure 3-29c).
Furthermore, EFA-6 isoforms interact with ARF-6[GDP] in a yeast two-hybrid assay
(Figure 3-29d).
Taken together, these results suggest that ARF-6 inhibits linker cell phagocytosis
onset, and blocks linker cell degradation together with its regulators EFA-6/GEF and
CNT-1A/GAP.
82

% 24h adults with linker cell corpse

a

% 24h adults with linker cell corpse

c

p<0.0001

p<0.0001

60

b efa-6p::GFP

40
20
0

100
WT

100
103
102
103
106
efa-6 cnt-1(0) cnt-1(0); arf-6 arf-6 (gf);
(ok3533)
efa-6 (0) (gf) efa-6 (0)
p<0.001

60
#^

40

#

#^

n.s.

20

0

103
100
103
WT arf-6(ns388) -

304
+UCp::
efa-6A

304
+UCp::
efa-6B

311
307
101
103
+UCp:: +UCp:: arf-6
ns763;
efa-6C efa-6D (ns763) efa-6(0)

efa-6(ok3533); arf-6(ns388)
d

ARF-6 ARF-6 ARF-6 ARF-6 ARF-6
(T44N) (T44N) (T44N) (T44N) (T44N)
e.v. EFA-6A EFA-6B EFA-6C EFA-6D
+His
-His

Figure 3-29. EFA-6 is the relevant ARF-6 guanine nucleotide exchange factor.
(a) Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker
cell reporter and him-5(e1490). Number of animals scored inside bars. Error bars,
standard error of the proportion. Fisher’s exact test. (b) efa-6 transcriptional reporter.
Caret, U.lp or U.rp cell. Arrowhead, linker cell. Top: GFP; bottom: DIC. Scale bar,
10 μm. (c) Histogram as in (a). UCp = lin-48p. Error bars represent standard error of the
proportion or standard error of the mean. Average of at least three independent lines.
#, significantly different from both efa-6(ok3533); arf-6(ns388) and arf-6(ns388). ^, only
one line out of three show significant rescue. n.s., p>0.05. (d) Yeast two-hybrid assay
with LexA-ARF-6[T44N] (GDP) as bait, GAD-EFA-6A-D as prey. Top: histidine present.
Bottom: histidine absence. Growth on -His plates indicates physical interaction.
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3.6. RAB-35 negatively regulates ARF-6 in linker cell corpse clearance
3.6.1. RAB-35 binds CNT-1A and drives ARF-6 removal from phagosome
membranes
rab-35(0) and arf-6(gf) mutants exhibit similar linker cell clearance defects. I
wondered, therefore, whether RAB-35 and ARF-6 proteins act in the same pathway.
I found that putative null mutations in arf-6 or efa-6 almost fully restore linker cell
clearance to rab-35 mutants (Figure 3-30, 3-31a). The arf-6[Q67L] CRISPR mutant
also suppresses rab-35(0) defects (Figure 3-31b), confirming this allele inactivates
ARF-6 and is not an ARF-6[GTP] mimetic (see above). Linker cell clearance defects
are restored to rab-35(b1013); arf-6(tm1447) double mutants by expressing wildtype arf-6 in U.l/rp cells, but not in the linker cell (Figure 3-31c). Furthermore, neither
mutations in cnt-1 nor the dominant arf-6 allele enhance the linker cell defects of rab-35

% 24h adults with linker cell corpse

mutants (Figure 3-31d). Finally, overexpression of YFP-RAB-35 in engulfing cells
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Figure 3-30. RAB-35 inhibits ARF-6.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard
error of the proportion. Fisher’s exact test. #, significant difference compared to
rab-35(b1013) and wild type.
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restores linker cell clearance to arf-6(ns388) mutants (Figure 3-30a). Taken together,
these results suggest that RAB-35 normally functions to inactivate ARF-6.
To understand how RAB-35 inhibits ARF-6, I first imaged mKate2-RAB-35 and
ARF-6-YFP localization in the same animal. Consistent with the other imaging studies,
the two proteins initially co-localize to extending U.l/rp cell pseudopods (Figure 3-32a,b).
RAB-35 then accumulates on the phagosome membrane, while ARF-6 enrichment
fades (Figure 3-32c,d, 8/9 animals). Next, I examined ARF-6-YFP dynamics in
rab-35(b1013) animals (Figure 3-32e-h). Remarkably, I found that ARF-6-YFP remains
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Figure 3-32. RAB-35
removes ARF-6 from
phagosome membranes.
(a-d) Localization of ARF6-YFP (top) and mKate2RAB-35 (middle) within the
U.l/rp cells examined during
linker cell (LC) death and
degradation in the wild type.
Bottom: merge, ARF-6-YFP,
green; mKate2-RAB-35,
magenta. Scale bar,
5 μm. (e-h) ARF-6-YFP
localization in rab-35(b1013)
mutant. LC labeled in
magenta. Scale bar, 5 μm.
(i-k) ARF-6(D92N)-YFP
localization in otherwise wildtype animals. LC labeled in
magenta. Scale bar, 5 μm.

on the membrane longer than in wild type animals (Figure 3-32g,h, 5/6 animals;
ARF-6-YFP removed 4.6 ± 0.9h after first contact in wild type animals vs 15.4 ± 9.7 h
in rab-35(b1013) where the corpse persists, p=0.023, Student’s t-test). Furthermore, in
wild-type animals, ARF-6(D92N) remains enriched on phagosome membranes longer
than ARF-6-YFP (Figure 3-32i-k, 4/4 animals; 19.1 ± 11.4h after first contact, p=0.01
compared to WT, Student’s t-test).
These results raise the possibility that RAB-35 promotes linker cell clearance,
at least in part, by facilitating ARF-6 removal from the phagosome. Consistent with this
notion, an ARF-6(D92N) gain-of-function protein is more effective in blocking linker cell
clearance than ARF-6(D92N) lacking a myristoyl group addition sequence, required for
membrane localization [214] (Figure 3-31e).
To determine whether ARF-6 localization is regulated by direct binding to RAB35, I assessed their interactions in a yeast two-hybrid system. While I did not detect
any interactions between these two proteins, I found that RAB-35[GTP], the active form
of RAB-35, binds CNT-1A (and not CNT-1B) (Figure 3-33). Thus, RAB-35 may recruit
CNT-1A to phagosome membranes, catalyzing conversion of active ARF-6[GTP] to
inactive ARF-6[GDP].

RAB-35 RAB-35 RAB-35 RAB-35 RAB-35 RAB-35
(S24N) (S24N) (S24N) (Q69L) (Q69L) (Q69L)
e.v. CNT-1A CNT-1B
e.v. CNT-1A CNT-1B
+His
-His

Figure 3-33. RAB-35 interacts with the ARF-6 GAP, CNT-1A.
Yeast two-hybrid assay with LexA-RAB-35[S24N] (GDP) or LexA-RAB-35[Q67L] (GTP)
as bait, Gal4-AD (GAD)empty vector, GAD-CNT-1A, or GAD-CNT-1B as prey. Top:
histidine present. Bottom: histidine absence. Growth on -His plates indicates physical
interaction.
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3.6.2. The RAB-35/ARF-6 module is not required for apoptotic cell
clearance
Given the roles of RAB-35 and ARF-6 in the clearance of a cell dying by LCD,
I wondered whether these proteins play similar roles in apoptotic cell clearance. To
test this, I counted the number of persisting apoptotic cells in 3-fold embryos, after
nearly all developmental cell death has taken place. In him-5 mutant control animals,
I counted 0.10 ± 0.30 persisting refractile corpses on average (N=21). In arf-6(ns388)
mutants, 0.47 ± 0.60 corpses were observed (N=21, p=0.0131, Student’s t-test).
rab-35(b1013) mutants exhibited 0.81 ± 0.92 corpses, on average (N=21, p=0.0018,
Student’s t-test). These small defects pale in comparison to defects exhibited by
mutants defective in canonical apoptotic engulfment genes (e.g. ced-7; ced-10 double
mutant: 16.8 ± 4.2 corpses, N = 11). Furthermore, rme-4 mutant embryos I tested
have no clearance defects (ns410: 0.14 ± 0.36 apoptotic corpses, N=14; ns412:
0.13 ± 0.33 apoptotic corpses, N=24). I also examined whether rab-35 mutations exhibit
genetic interactions with canonical apoptosis engulfment genes in linker cell death, but
found no such interactions (Table 3-4).
Our results, therefore, demonstrate that the RAB-35/ARF-6 module plays specific
roles in dismantling the linker cell that are not shared with clearance of apoptotic cells in
C. elegans.
3.7. Discussion
3.7.1. A New Engulfment and Degradation Pathway for Non-Apoptotic
Dying Cells
In this section, I demonstrate that the clearance machinery promoting the
removal of the linker cell, which dies by LCD, differs from that used to clear apoptotic
cells in C. elegans. These studies uncover a protein network promoting linker cell
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Table 3-4. Mutations in the canonical apoptotic engulfment genes ced-1 and ced-5
do not enhance mutations in rab-35.
(mean ± SE of proportion).
Genotype
% linker cell corpses in 24h adults N
WT
12 ± 3.2
100
ced-1(e1735)
ced-5(n1812)a
rab-35(b1013)
rab-35(tm2058)
sand-1(ok1963)

14 ± 3.4
12 ± 2.9
74 ± 4.2
69 ± 4.6
58 ± 4.8

103
125
105
99
104

ced-1; rab-35(b1013)
ced-5; rab-35(b1013)
ced-1; ced-5; rab-35(b1013)

77 ± 4.2
63 ± 4.8
62 ± 4.8

101
101
103

ced-1; rab-35(tm2058)
ced-5; rab-35(tm2058)
ced-1; ced-5; rab-35(tm2058)

56 ± 4.9
58 ± 4.9
63 ± 4.7

102
102
104

sand-1; rab-35(b1013)b
95 ± 2.7
63
a
b
= nsIs1[lag-2p::GFP, rol-6(+)]. = animals scored at 36h post L4-adult transition to
account for slow growth of double mutant. All animals carried a him-5(e1490) mutation
and a GFP linker cell marker.

engulfment and degradation (Figure 3-34a). I find that RAB-35 and ARF-6 play key
early roles, controlling the sequential loading of phagosome maturation factors onto
the phagosome membrane (Figure 3-34b). These data are consistent with a model in
which RAB-35[GTP] promotes elimination of dying cells by blocking the activity of an
inhibitor of the process, ARF-6[GTP]. These studies are the first to implicate a RAB-35/
ARF-6 module in the engulfment and degradation of dying cells, define in detail multiple
accessory factors, identify the relevant targets (e.g. RAB-7) and, importantly, explore the
functions of these proteins in vivo in a living multicellular animal.
Although I identifed the LCD corpse engulfment pathway in C. elegans, a number
of studies in other systems raise the possibility that this process may be conserved.
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Figure 3-34. A model for control of linker cell degradation by the RAB-35/ARF-6
module.
(a) RAB-35:GTP promotes linker cell degradation by interacting with the ARF-6 GAP
CNT-1. CNT-1 is required for turning ARF-6 off and removing it from the membrane.
ARF-6:GTP inhibits linker cell degradation. GAP, GTPase activating protein. GEF,
guanine nucleotide exchange factor. (b) 1. ARF-6 and RAB-35 surround the nascent
phagosome. 2. RAB-35 recruits CNT-1. 3. CNT-1 turns off ARF-6, removing it from the
phagosome membrane. RAB-35 remains on the membrane. 4. RAB-5 is recruited.
5. RAB-7 recruitment and RAB-5 loss. 6. RAB-35 is largely gone from the membrane
once the lysosome (CTNS-1) fuses with the phagosome.
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For example, in Drosophila, nurse cell death is thought to be caspase independent,
and knockdown of RAB-35 results in persistent nurse cell nuclei [72]. While the role of
RAB-35 was not further investigated, the involvement of this protein in a non-apoptotic
setting is intriguing. Furthermore, concerted activities of RAB-35 and ARF-6 in other
contexts have been described, including neurite outgrowth, cytokinesis, oligodendrocyte
differentiation, maturation of recycling endosomes, and FcγR-mediated uptake of
bacteria by macrophage [215-219]. In some of these cases, interactions between
RAB-35 and putative ARF-6 GAPs are seen [220]. Additionally, ARF-6 is known to
function in endocytosis of yolk proteins in C. elegans [221]. There it works with RAB-10
in a similar regulatory cascade as the one we have uncovered.
3.7.2. New Ways to Generate ARF[GTP] Mimics
My genetic analysis of linker cell engulfment yielded important reagents, likely
to be of utility in studying ARF-family proteins. I found that a Q67L mutation in ARF-6,
which is predicted to mimic the GTP-bound state of the protein, behaves instead
as a functional null in our assay. This modification, effective in the context of other
GTPases, may, therefore, result in protein instability, or loss of active conformation.
However, I found that the ARF-6(D92N) mutant protein, or a protein carrying two
lesions, ARF-6(I42M;P43T), appear to mimic ARF-6[GTP], and if anything, enhance
protein stability. Based on the published structure of Arf6 binding to the ArfGAP ASAP3
[212], the D92N mutation is adjacent to a residue that coordinates to a key valine in
the ArfGAP, whereas the I42M,P43T double mutations modify residues that directly
coordinate to known GAP catalysis residues [212]. I propose that these lesions could
keep the protein locked in the GTP-bound state, because they prevent GAP protein
binding. This interpretation is bolstered by the protein interaction studies. I propose that
introducing similar lesions into other ARF proteins, and perhaps into other GTPases,
could allow for the development of new GTP-bound mimetics of these proteins.
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3.7.3. Competitive Phagocytosis
In addition to unique molecular components, I found that the mechanics of
linker cell engulfment are very different from engulfment of apoptotic cells. The
imaging studies reveal a process of competitive phagocytosis, where two phagocytes
compete to engulf portions of the linker cell, resulting in cell splitting. RAB-35 acting
through ARF-6 prevents premature activation of this engulfment process. As with
the molecular constitutes of linker cell engulfment and degradation, I believe that the
process of competitive phagocytosis may also be conserved. In macrophage-less
mice, for example, mesenchymal cells engulf dying neighbors during digit formation,
and occasionally two mesenchymal cells can be seen engulfing the same dying cell in
transmission electron microscopy images [222]. Consistent with this process involving
new engulfment regulators, mesenchymal cells do not express the CED-7 homolog
ABC1 [222]. Similarly, in developing rat cerebellum, more than one non-professional
phagocyte can be seen engulfing a dying cell [223]. A related process has been
documented during germ cell development in C. elegans. Primordial germ cells extend
cytoplasm-containing lobes into the adjacent endoderm, and the lobe is excised from
the remaining cell, in a process reminiscent of competitive phagocytosis [224].
The need for engulfment by more than one cell could be related to the size of
the dying cell. For example, when macrophages attempt to engulf a particle that is too
large, engulfment is stalled [225,226]. Engulfment by two or more cells could solve
this problem. However, in this case, cytoplasmic spillage must be avoided. The new
engulfment process I describe here accomplishes exactly that.
A process reminiscent of competitive phagocytosis can also be seen when
cultured human peripheral blood monocytes engulf a C. albicans pathogen [227].
Similarly, cultured mouse monocytes simultaneously engulf a Leishmania parasite [227].
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One cell engulfs the flagellum, while the other engulfs the posterior pole. In this context,
roles for RAB-35 in pathogen clearance [178,215,220] are especially intriguing, and
may suggest underlying mechanisms similar to linker cell clearance.
In summary, I demonstrate that engulfment and degradation of a cell that dies
by LCD requires mechanics and machinery different from that used for apoptotic cell
engulfment and degradation, and identify a molecular pathway governing this novel form
of cell clearance. Given the conservation of LCD, I propose that this ancillary process
may be conserved as well.
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4. CED-3 is required for linker cell corpse degradation but not death
The linker cell dies independently of all known cell death genes, including
members of the apoptotic pathway [82,83]. Knowing this, I was quite surprised when
Holly Johnsen, a graduate student in Bob Horvitz’s lab at MIT, came up to me at a
meeting to let me know that she had seen ced-3 transcripts in the linker cell while
examining the role of caspase of other cells in the tail. I rechecked the surviving linker
cell defects, and confirmed that the cells are still dying by the strict morphological
defects to which we adhere. Interestingly, I noticed that ced-3 and ced-4 mutants
instead had an increased number of cell corpses, suggesting that perhaps these genes
are involved in corpse degradation, but not death.
4.1. CED-3 and CED-4 are required for efficient degradation
I reexamined the genes involved in apoptosis and found that the linker cell still
dies, as evidenced by a crenellated nuclear envelope (Table 4-1). Instead, linker cell
corpses in ced-3 and ced-4 animals persist, while corpses in ced-9 or egl-1 animals
are largely cleared (Figure 4-1). To examine this further, I imaged ced-3 animals using
the microfluidic set up. I found no difference in development events compared to wild-

Table 4-1. The linker cell dies in the absence of apoptotic genes.
Genotype
egl-1(n1084n3082)a
ced-9(n1950)a
ced-4(n1162)
ced-3(n717)
ced-3(n2452)

% SLCs (N)
0 (47)
6% (51)
0 (40)
0 (47)
0 (45)

= nsIs1[lag-2p::GFP, rol-6(+)]. All animals carried a him5(e1490) mutation and a GFP linker cell marker.
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Figure 4-1. Linker cell corpses in ced-3 and ced-4 mutant animals are not
degraded.
Linker cell degradation in indicated genotypes. Strains contain either lag-2p::GFP linker
cell reporter or nsIs1[lag-2p::GFP, rol-6(+)] (denoted by ^) and him-5(e1490). Number of
animals scored inside bars. Error bars, standard error of the proportion. Fisher’s exact
test.

type animals (e.g. tail tip retraction onset, Figure 4-2a-c). I also found no difference in
onset of nuclear crenellation, suggesting that the death kinetics are similar between
ced-3 animals and wild-type animals (Figure 4-2e). I did notice, however, that ced-3
animals lagged in most aspects of corpse degradation. There was a delay in linker cell
corpse rounding, which sometimes never occurred (Figure 4-3a). This result suggests
that ced-3 corpses may have a delay in engulfment, which is corroborated by the
observation that cell splitting is delayed in these animals (Figure 4-3b). There was also a
delay in the formation and the duration of the refractile corpse (Figure 4-3c,d). Both the
small fragment and the large fragment persisted longer than in wild type (Figure 4-3e,f),
although the duration of the small fragment was unchanged (Figure 4-2f).
While there is a delay in phagocytosis, ced-3 corpses are terminally engulfed 24h
after the L4 to adult transition (Table 4-2). In agreement with this, ced-3 mutant males
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Figure 4-2. ced-3 mutations do not affect male developmental events.
(a-f) Strains contain linker cell reporter [mig-24p::Venus], U.l/rp cell reporter
[lin-48p::mKate2], and him-5(e1490) for males. Dots, individual events in single animals
in hours with respect to first contact. X, event did not occur and was not factored into
statistical analysis. Bars, mean ± std. n.s., p>0.05, Student’s t-test. Wild type (WT) same
animals as in Chapter 3.
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are fertile, suggesting no interference between a lingering unengulfed linker cell and
spermatid release [5].
To further bolster the hypothesis that CED-3 is involved in degradation rather
than killing, I created ced-3; pqn-41(ns294) double mutants and found that loss-offunction mutations in ced-3 did not enhance the surviving linker cell defects of pqn-41
animals (Table 4-3).
4.2. ced-3 and ced-4 act in the linker cell
Since corpses persist in both ced-3 and ced-4 mutants, I wanted to determine
where these genes are expressed and where they function.
4.2.1. ced-3 expresses in the linker cell as it dies, but not as it migrates
I examined two transcriptional reporters, nsIs25[ced-3p::GFP] and
nsEx4944[ced-3p::mCherry]. In both cases, I saw expression of fluorescent protein in
the linker cell once it reached the cloaca, but not as it was migrating (Figure 4-4a,b).
I noticed that expression in the linker cell was much fainter than other cells dying
by apoptosis in the male tail (Figure 4-4a,b), suggesting that ced-3 is not induced
as strongly when required only for cell clearance. I also obtained bcIs109, a ced-3
translational reporter, and found GFP puncta in the nucleus of the dying linker cell,
consistent with a role in nuclear degradation (Figure 4-4c). I did not see expression in
the U.l/rp cells from any of the reporters.
4.2.2. ced-4 is expressed in the linker cell
I created a ced-4 transcriptional reporter and noticed expression in both the dying
(Figure 4-5a) and migrating linker cell (Figure 4-5b). I also saw off-target overexpression
artifacts in the intestine (Figure 4-5b). Nonetheless, perhaps this low-level expression in
the migrating cell explains why ced-3 must be transcriptionally induced, to prevent being
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Table 4-2. Linker cell corpses in degradation mutants are terminally engulfed.
% linker cell corpses engulfed
in 24h adults
100

Genotype
WT

N
3

arf-6(ns388)
rab-35(b1013)
rme-4(ns410)

92
99
99

97
119
102

ced-3(n717)
ced-3(n2452)
ced-4(n1162)
ced-9(n1950)

99
99
91
89

100
101
100
19

ced-3(n2452); rab-35(tm2058)
ced-3(n2452); rab-35(b1013)
ced-3(n717); rab-35(tm2058)
ced-3(n717); rab-35(b1013)

98
100
99
99

102
107
72
76

All animals carried a him-5(e1490) mutation, a GFP linker cell marker, and an
mCherry U.l/rp cells marker.

Table 4-3. ced-3(lf) does not enhance the surviving linker cell defects of pqn41(ns294).
Genotype
Wild type
pqn-41(ns294)
pqn-41(ns294); ced-3(n717)
pqn-41(ns294); ced-3(n2452)

%SLC (N)
2h adults
3% (157)
20% (44)
24% (50)
20% (114)

All animals carried a him-5(e1490) mutation and a GFP linker cell marker.
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a ced-3p::mCherry

b ced-3p::GFP

c ced-3p::ced-3-GFP

Figure 4-4. ced-3 is expressed in the dying
linker cell.
(a-c) Caret, cells dying by apoptosis.
Arrowhead, linker cell. (a,b) ced-3
transcriptional reporter expression. (c) ced-3
translational reporter expression and
localization.

a ced-4p::mKate2

b ced-4p::mKate2

Figure 4-5. ced-4 is expressed in the
dying and migrating linker cell.
ced-4 transcriptional reporter in (a) linker
cell (arrowhead) at cloaca and (b) linker
cell (arrowhead) migrating. Top: mKate2;
bottom: DIC.
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activated by CED-4 prematurely. Together, these results suggest that CED-4 is present
in the migrating linker cell, and ced-3 is transcriptionally induced upon death initiation to
begin its degradation function.
4.2.3. ced-4 functions in the linker cell, not the engulfing cell
Since both ced-3 and ced-4 are expressed in the linker cell, but not in the U.l/rp
cells, I wanted to confirm that these proteins function within the linker cell. Because
expression of ced-3 ectopically in the linker cell may cause apoptotic cell death, I
examined ced-4 function instead. I expressed ced-4 cDNA under a linker-cell-specific
promoter (mig-24p) and a U.l/rp-promoter (lin-48p), and checked for rescue of the
ced-4(n1162) defect. I found that expression in the linker cell, but not the engulfing cells
rescued the phenotype (Figure 4-6), confirming that CED-4 functions in the linker cell to

% 24h adults with linker cell corpse

degrade it.

p<0.0001

80

n.s.
60
40
20
0

102

-

306

302

+UCp:: +LCp::
ced-4 ced-4
ced-4(n1162)

Figure 4-6. CED-4 functions in the dying linker cell.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). UCp, lin-48p. LCp, mig-24p. Number of animals scored
inside bars. Average of at least three independent lines. Error bars, standard error of
the proportion or standard error of the mean. n.s., p>0.05, Fisher’s exact test.
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4.3. Interactions between RAB-35/ARF-6 module and caspase
In the previous chapter, I described a RAB-35/ARF-6 module that is required for
corpse degradation in the U.l/rp cells, and how it is necessary for proper phagosome
maturation. CED-3 is also required in the linker cell to aid in its engulfment and degrade
components of the nucleus. Because both are involved in some aspect of corpse
degradation, I wanted to determine if and how these pathways interact.
4.3.1. ced-3 is still expressed when rab-35 and arf-6 are mutated
I wanted to determine if ced-3 expression is affected when the RAB-35 or
ARF-6 pathways are disrupted. To test this, I crossed the ced-3 transcriptional reporter
into rab-35(b1013) and arf-6(ns388) animals. In both cases, ced-3 is still expressed
(Figure 4-7). This result is consistent with the idea that ced-3 is induced after cell death,
but upstream of phagosome maturation.
4.3.2. ced-3 likely functions upstream of rab-35
To determine if there are any genetic interactions between the pathways, I
created double mutants between ced-3, and rab-35 and its GAP, tbc-10. I found no
synergistic interactions (Figure 4-8), but these corpses more closely resembled ced-3
corpses, suggesting it functions upstream of rab-35. I also wanted to determine if

a ced-3p::GFP in rab-35(b1013)

b ced-3p::GFP in arf-6(ns388)

Figure 4-7. ced-3 is still expressed in rab-35 and arf-6 mutants.
ced-3 transcriptional reporter in (a) rab-35(b1013) and (b) arf-6(ns388) animals.
Arrowhead, linker cell.
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% 24h adults with linker cell corpse

100
80
60
40
20
0

114
102
105
99
99
97
ced-3
ced-3 rab-35 rab-35 n2452; n2452;
(n2452) (n717) (b1013) (tm2058) b1013 tm2058

101
n717;
b1013

99
n717;
tm2058

103
n717;
tbc-10

110
n2452;
tbc-10

Figure 4-8. ced-3 and rab-35 do not genetically interact.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard
error of the proportion. n.s., p>0.05, Fisher’s exact test.

recruitment of YFP-RAB-35 is defective in ced-3 mutant animals using the microfluidic
long-term imaging set up and imaging over the duration of linker cell clearance. I was
unable to detect any consistent differences in YFP-RAB-35 localization or intensity
between WT and ced-3, suggesting that RAB-35 function is unperturbed in ced-3
animals.
4.3.3. ced-3 and arf-6(gf) are synergistic
Intriguingly, I found that ced-3 and arf-6 pathways interact. Double mutants
between arf-6(gf) and ced-3(lf) are synergistic, while null mutations in arf-6 do not affect
the phenotype of ced-3 animals (Figure 4-9).
As noted in Chapter 3, ARF-6-YFP localizes to either the dorsal or the
ventral side of the engulfing cell. In ced-3 animals, the intensity of ARF-6-YFP when
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n2452
arf-6
n717
n2452
ns388 (tm1447) tm1447 tm1447

Figure 4-9. ced-3 and arf-6 pathways interact.
Linker cell degradation in indicated genotypes. Strains contain lag-2p::GFP linker cell
reporter and him-5(e1490). Number of animals scored inside bars. Error bars, standard
error of the proportion. n.s., p>0.05, Fisher’s exact test.

localized to the ventral side of the cell, or to both the ventral and dorsal sides was
unaffected (Figure 4-10). Intriguingly, when ARF-6-YFP localized to the dorsal side
alone, both the intensity and duration was reduced in ced-3 animals (Figure 4-11).
Perhaps this result may have something to do with the role of ced-3 in engulfment
receptor presentation, and may hint at an additional function of ARF-6 in wild-type
animals.
4.4. Discussion
I found that the caspase CED-3 and its upstream activator CED-4 are required
for linker cell corpse degradation, perhaps having a role in engulfment receptor
presentation and nuclear degradation. Neither of the proteins are required for death,
as the linker cell corpse displays nuclear crenellation and is eventually engulfed in the
absence of these genes.

104

10000

WT

ced-3 ventral/posterior

intensity [a.u.]

8000

ced-3 d+v

6000
4000
2000
0

0

200

400
time [min]

600

800

Figure 4-10. ARF-6-YFP intensity is unaffected when localized only on the ventral
arm of the pseudopod or on both arms in ced-3 mutants.
The intensity of ARF-6-YFP around the linker cell during linker cell death and
degradation was monitored in the microfluidic device over at least 20 h. Total intensity
values were plotted as a function of time. Wild type (WT) localization (ventral/posterior
localization) in blue, ventral/posterior localization in ced-3(n2452) in light pink, and
dorsal+ventral localization in ced-3(n2452) in dark pink.

I noticed that the majority of corpses in ced-3 animals were small, consisting
solely of a crenellated nucleus with little cytoplasm remaining. Based on the long-term
imaging studies, I know that this small cell is the larger fragment, where the cytoplasm
has been removed, and only the nucleus remains. Perhaps CED-3 is responsible for
presentation of engulfment receptors and degradation of the nucleus, but not nuclear
envelope changes or bulk cytoplasmic degradation. Further investigation is necessary
to determine how CED-3 is affecting cell splitting and cell engulfment. Intriguingly, the
ced-3 linker cell corpse morphology is reminiscent to that of dying motoneurons in the
absence of the pro-apoptotic Bax [112]. Those cells are also small with shriveled nuclei
and do not maintain synaptic connections, suggesting they are dead, but not degraded.
Perhaps in that system, LCD is the main driver of cell death, and caspase is required to
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Figure 4-11. ARF-6-YFP intensity and duration is affected when localized only on
the dorsal arm of the pseudopod in ced-3 mutants.
The intensity of ARF-6-YFP around the linker cell during linker cell death and
degradation was monitored in the microfluidic device over at least 20 h. Total
intensity values were plotted as a function of time. Wild type (WT) localization (dorsal
localization) in blue, dorsal localization in ced-3(n2452) animals in pink.

clear the corpse debris.
A role of ced-3 in degradation rather than killing is also supported from its known
targets. The majority of caspase targets identified could actually be required mostly
for corpse cleanup, instead of death. For example, in apoptosis in C. elegans, CED-3
cleaves DCR-1 to convert it from an RNase to a DNase and degrade DNA in dying cells
[228]. In mammalian cells, effector caspases activate a DNase to degrade the DNA as
well [111]. While bulk cleavage of DNA would presumably lead to cell death, the primary
function could actually be nuclear clearance after phagocytosis. Determining the exact
timing of death, caspase activation, DNA degradation, and corpse removal will be key in
determining the primary, likely extremely nuanced function of caspase in dying cells.
The ability of caspases to carry out nuanced cell function is well-documented.
Controlled expression of caspase either by levels or location can have a wide variety
of consequences in development. For example, in C. elegans, CED-3 is known
to cleave LIN-14, LIN-28, and DISL-2, which are key regulators of developmental
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timing [229,230]. These cleavage events allow for robust development of the
worm. In Drosophila, controlled activation of caspase is required for proper sperm
development [231]. Based on these examples, the idea that caspase is a bulk killing
machine is likely incorrect, but that its activation in cell death, degradation, and other
proteolytic events is likely distinct and very well-controlled.
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5. Discussion and future directions
5.1. A model for linker cell death and degradation
During my graduate studies, I discovered components required for both linker cell
death and degradation. I found that HPK-1, a homeodomain protein kinase, interacts
with the polyglutamine protein PQN-41C. This interaction may disrupt the positive
interactions between HPK-1 and the heat shock function of HSF-1, perhaps allowing
HSF-1 to undertake its linker cell killing role. After linker cell death, I found that the
U.l/rp cells simultaneously engulf the dying cell, eventually leading to cell splitting and
internalization. Precocious competitive phagocytosis occurs in animals lacking the small
GTPase rab-35, or in a gain-of-function mutant of arf-6. In these animals, phagosome
maturation fails to proceed, although engulfment itself is unaffected. Linker cell corpse
degradation also requires the caspase ced-3 from within the linker cell for efficient
removal.
The linker cell requires both external (i.e. RAB-35) and internal (i.e. CED-3)
proteins for proper corpse elimination. Perhaps these extra layers of degradation ensure
that the linker cell is properly cleared, as removal of the linker cell from the gonadal
tube is absolutely essential for male fertility. Multiple avenues of corpse removal would
therefore be prudent to guaranteeing male fertility and propagation of genetic material.
One of the few pro-survival factors targeted by CED-3 in C. elegans is
CNT-1 [232]. In apoptosis, CNT-1 interacts with Akt signaling to promote cell survival,
and cleavage of CNT-1 by CED-3 removes this function [228]. It is quite interesting that
I also found a role for CNT-1, although in a different context. In linker cell phagosome
maturation, CNT-1 is required to turn off ARF-6 through recruitment by RAB-35. Given
that ced-3 and arf-6(gf) genetically interact, one might suspect that CNT-1 is the link.
A few pieces of evidence dispute this, however. First, CNT-1 acts in the engulfing cell,
while CED-4, and by proxy, CED-3, act in the linker cell. Second, using CRISPR, I
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removed the CED-3 cleavage site in the endogenous cnt-1 locus, and I found no effect
on linker cell degradation, suggesting that CED-3 cleavage of CNT-1 is dispensable for
linker cell corpse removal.
The use of caspase to degrade the linker cell, but not to kill it, shows the fine line
between death and degradation, and how difficult it may be to distinguish between these
phenotypes. In linker cell death, however, I think caspase is involved in downstream
degradation events, because persistent linker cell corpses in ced-3 mutant animals
have lost a majority of their cytoplasmic volume and are much smaller than typical
surviving cells. In addition, the nuclear envelope is crenellated. This phenotype has
been confirmed by scientists in external laboratories, and is even the case in quadruple
caspase mutants [83].
Instead ced-3 mutant animals have difficulty with internalization of the cell
corpse, as evidenced by the delay in cell splitting. They also have trouble in digesting
the fragments after internalization, especially the larger nuclear fragment. While these
animals also have a delay in removal of the small, cytoplasmic piece, the actual duration
of this piece is unaffected. This means that it takes longer for the animal to generate
the smaller fragment, but this piece is degraded efficiently once it is. Intriguingly,
ced-3 persistent linker cell corpses resemble dying motoneurons in the absence of
apoptosis [112]. Perhaps these cells are dying by LCD and are then being degraded via
caspase activation. Another alternative is that both cell death forms are used to kill and
degrade the cell of interest, depending on developmental stage, signaling pathways,
and the local environment.
5.2. A new function of caspase and an alternative explanation of published
results
Caspase-dependent apoptosis does not account for many cell death events that
occur during animal development. Indeed, mice homozygous for knockout alleles of key
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apoptotic genes, including caspase-3, caspase-9, Apaf1, or Bax and Bak, can survive
to adulthood [33,36,233], a surprising observation given the prevalence of cell death in
murine development. Inactivation of apoptosis genes also only weakly interferes with
degenerative disease progression [234]. LCD, a non-apoptotic cell death process, is
prevalent in vertebrates [235] and may account for a significant fraction of cell deaths
that take place during development and in disease.
From our studies, it is apparent that caspase is instead needed for bulk cell
degradation, as well as a more specific function in engulfment. Perhaps some of
present apoptotic data could also be explained by this alternative function of caspases.
For example, in Bax-Bak- mice, cell death between the digits is greatly delayed [38].
However, since the morphology of these dying cells was not examined by electron
microscopy, one could imagine a scenario where caspase activation is needed only
after LCD has commenced in these cells.
Indeed, in collaboration with Sarit Larisch and Dana Mamriev at the
University of Haifa, we noticed that mouse embryonic fibroblasts (MEFs) display
LCD-like morphology only 8 min after treatment with the cell-death-inducing drug
staurosporine (STS) (M. Alam, unpubl. data). In HeLa cells treated with STS, the
initiator caspase-9 is activated 30 min after treatment, and the effector caspase-3 is
induced 3h after treatment [236]. Caspase-3 activation peaks 12h after STS treatment
in human corneal endothelial cells, and the cells adopt apoptotic morphology 12h after
treatment [237]. These results suggest that LCD could be the main killing function, with
caspase responsible for clearing cellular debris.
The LCD-like crenellations still occur in treated MEF cells with mutated apoptotic
genes (D. Mamriev, M. Alam, unpubl. data). We also noticed induction of components
of the ubiquitin proteasome system 30 min after treatment (L. Kutscher, D. Mamriev,
unpubl. data). While the research is still early, this system mimics what we see with the
death of the linker cell.
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Perhaps there are other pathways that were initially thought to be exclusively
apoptotic that instead rely on apoptotic genes for efficient corpse clearance, and not for
death. Given the diversity of non-apoptotic functions for caspase [238], then perhaps it
is not so far-fetched that caspase has a nuanced role in cell death.
5.2.1. Suggestions for classifying cell death in vivo
How then should we classify apoptosis versus LCD, especially given that
molecules between the two may be shared but have distinct functions? First, I would
argue that ultrastructural morphology is important for identifying the relevant pathway.
LCD and apoptosis have distinct morphology by electron microscopy (EM), and this
could be used as a first step in identifying the cell death process at play. As EM methods
require specialized training and equipment, it may not always be available. Perhaps in
this case, nuclear morphology is the best indication of LCD vs. apoptotic. Expression
of fluorescently tagged lamin in cells dying by LCD revealed that the crenellations are
visible with light microscopy (M. Alam, unpubl. data).
The presence of cleaved caspase-3 should no longer be considered a proxy
for apoptosis, given the role of CED-3 in corpse clearance of cells dying by LCD.
Determining exactly how to differentiate between these cell death pathways will
hopefully become clearer as we learn more about the relative contributions each makes
to eliminate a dying cell.
5.2.2. LCD and apoptosis as parallel pathways?
One possibility is that LCD drives cell death in development, while caspases
perform a cell degradation role. Another possibility is that the two pathways work in
parallel, each functioning in certain developmental stages and contexts. Perhaps LCD
is the main cell death program in vertebrate systems, especially since mutations in
apoptotic genes only affect certain tissues. Finding the molecules conserved across
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species will be crucial in testing these hypotheses. Many of the LCD genes isolated so
far, including the ones described in this thesis, may be nematode-specific, as most of
the upstream regulatory genes isolated tell the linker cell exactly when and where to die.
The key will be identifying the genes targeted by the ubiquitin proteasome system, and
determining if those molecules are conserved across systems.
5.3. Future directions
While my graduate work revealed a substantial amount about the genes and
mechanisms involved in linker cell death and degradation, many pertinent questions
remain. Discussed below are some that I consider most pressing in relation to my work.
5.3.1. Linker cell death future questions
Chapter two of my thesis focused on the role of PQN-41C interacting proteins
in cell death. I recovered many interesting candidate genes that warrant additional
investigation, including the aconitase aco-2, the zinc finger protein zfp-1, two additional
polyglutamine-containing genes pqn-59 and pqn-85, and the cell death inhibitor hpk-1.
I am especially interested in how these interactions with PQN-41C contribute to cell
death, especially since neurodegenerative diseases associated with polyglutamine
expansion proteins may result from a developmental cell death program gone awry [94].
5.3.1.1.

Does PQN-41C bind HPK-1 to prevent it from activating HSF-1?

I isolated the homeodomain protein kinase HPK-1 as an interacting partner of
PQN-41C. Genetic experiments placed HPK-1 with HSF-1, and additional preliminary
experiments showed that loss of hpk-1 affects HSF-1 heat shock function and abrogates
the heat-related cell death defect of the linker cell. A positive regulatory interaction
between HPK-1 and HSF-1 in modulating the stress response is bolstered by previously
published data in C. elegans [186,196,197] and other organisms [188,239].
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Because loss of hpk-1 allows cell death to occur more robustly, I hypothesized
that HPK-1 normally promotes the stress-related, pro-survival role of HSF-1, and that
an interaction with PQN-41C is necessary to disrupt this interaction. This would then
allow HSF-1 to function in its pro-death capacity instead. However, it seems necessary
for HPK-1 to function prior to death, as loss of hpk-1 affects male fertility. Further work
should directly test this hypothesis. Ideally, this would be tested biochemically, as
discussed in Chapter 2. Another, perhaps simpler way to test this hypothesis, would
be to mutate putative Ser/Thr phosphorylation residues to alanines on HSF-1 and test
for rescue in hsf-1(sy441) animals. By doing this as a single copy insertion under the
endogenous promoter, one could test these residues for their role in both the heat shock
response globally, as well as their role in linker cell death specifically.
5.3.1.2.

How does HPK-1 regulate HSF-1 in its heat shock role?

One added benefit to the above method is that we could simultaneously identify
amino acid residues necessary for both functions of HSF-1 in a single experiment.
In other systems, HPK-1 inhibits the ability of HSF-1 to become sumoylated, which
bolsters its heat shock response [196]. Alternatively, in response to increased levels
of reactive oxygen species (ROS), the HPK-1 homolog, HIPK2, is desumoylated,
which drives downstream gene expression changes [239]. Perhaps in linker cell
death, when HPK-1 is inhibited, HSF-1 becomes sumoylated, pushing HSF-1 towards
its cell death role. Identifying sumoylation sites computationally and attempting to
rescue hsf-1(sy441) with lysine to alanine mutations at these residues may help
identify putative sumoylation sites on HSF-1. The role of sumoylation in modifying and
modulating HSF-1 and HPK-1 in linker cell death definitely deserves closer inspection.
Adding to the intrigue, Jennifer Malin identified the E3 sumo-conjugating enzyme
UBC-9 as a putative substrate of the E3 ligase BTBD-2 in linker cell death. Perhaps
selective removal of a sumoylation-promoting enzyme is required to kill the linker cell.
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Identifying the post-translation modifications necessary to modulate the different roles
of HSF-1 is crucial to fully understanding the interactions between these proteins, and
learning how the cell decides between life and death.
5.3.2. Linker cell degradation future questions
Chapters 3 and 4 of my thesis focused on the events that occur after linker cell
death, namely how is the dying linker cell cleared from the organism. I discovered a
core genetic network involving the two small GTPases ARF-6 and RAB-35, whose
interplay is required for proper phagosome maturation and cell degradation. I also
discovered that caspase is required in the linker cell to be properly engulfed by the
U.l/rp cells and for the nucleus of the linker cell to be properly degraded. While I
uncovered quite a bit about the dismantling of the cell corpse, some questions remain
and are discussed below.
5.3.2.1.

How is the cell specificity of ARF-6 and RAB-35 function conferred?

One puzzling piece remaining is the fact that the U.l/rp cells seem specifically
equipped to dismantle the linker cell, yet both arf-6, rab-35, and many of their regulators
are expressed throughout the entire animal. Overall, animals harboring mutations in
these genes do not have major issues in viability, although these genes have additional
endocytic and membrane trafficking functions [207,210]. Perhaps one aspect of
specificity could be downstream effectors of these genes that have yet to be identified,
which equip the U.l/rp cells with specialized phagocytosis and degradation functions.
5.3.2.2.

How is the dying linker cell corpse recognized?

Both RAB-35 and ARF-6 have roles in phagocytosis onset and phagosome
maturation. It is still unknown, however, what the exact signaling molecules and
engulfment receptors displayed on the linker cell membrane are. We know that
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canonical apoptotic genes are not involved, and PS exposure was also not readily
detected. I think the linker cell is emitting a “find me” signal though, as I occasionally
witnessed dying cells that had a slight migration defect, where the U.l/rp cells extended
processes and appeared to pull the linker cell into its proper place. At the same time,
it also must have highly regulated “eat me” and “don’t eat me” signals, as competitive
phagocytosis and internalization should not take place before the linker cell is
completely sandwiched between the two engulfing cells and the gonad contents are
protected. What these signals are should be a future area of active investigation.
What is the best way to go about finding these molecules? I would suggest
revisiting my forward genetic screen, but this time carrying out the screen in animals
carrying both a U.l/rp marker (nsIs589) and a linker cell marker (nsIs65). I would
suggest picking off young adult males with intact linker cells under low magnification
(dissecting microscope), but then immediately mounting these males on a slide for
examination under high magnification (compound microscope). By doing so, it will be
easier to identify surviving cells based on DIC morphology, and perhaps also cells that
remain sandwiched but unengulfed within the U.l/rp cells (but still display a crenellated
nuclear envelope, indicating death). After recovery, I would suggest isolating each male
with a single wild-type hermaphrodite for 24h, to ensure that these males are infertile
(because a surviving or unengulfed linker cell will block spermatid exit). Only then would
I suggest attempting the artificial insemination (AI) procedure with these 24h old males,
noting also whether the linker cell is still around prior to AI. By more carefully conducting
the forward genetic screen can we find genes specifically involved in death or dying cell
recognition.
5.3.2.3.

What other genes are involved in corpse degradation?

We discovered that RAB-35 seems to be required to remove ARF-6 from the
nascent phagosome, and RAB-35 also has downstream functions involving RAB-5
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and RAB-7 recruitment. Based on sand-1; rab-35 double mutants, which have nearly
all cell corpses remaining even 36h after the L4 to adult transition, I think that RAB-35
is required in parallel to sand-1, at the RAB-5 to RAB-7 transition. This hypothesis is
bolstered additionally by the fact that while in the majority of rab-35(b1013) animals,
mCh-RAB-5 was never recruited to the phagosome, there was one animal where
mCh-RAB-5 persisted around the phagosome for nearly the entire experiment,
suggesting that RAB-35 is necessary for its removal. This is especially surprising for
RAB-5, as it is usually only enriched around the phagosome for a single frame in wildtype animals. For mCh-RAB-7 localization in rab-35 mutant animals, I never saw such
persistent localization, despite screening more animals.
To pinpoint the ARF-6-independent function of RAB-35 more precisely, I
should examine mCh-RAB-5 and mCh-RAB-7 localization in persistent cell corpses in
arf-6(tm1447); rab-35(b1013) double mutant animals. These animals have a small but
significant increase in the number of cell corpses compared to wild type, so that such
analysis would be possible. If my above idea is true, I should see persistent mCh-RAB-5
recruitment around these lingering corpses, and never see mCh-RAB-7 recruitment.
5.3.2.4.

What are the target proteins of CED-3?

I also determined that CED-3 is required for proper corpse degradation,
especially of the nucleus-containing fragment, and perhaps also plays a role in timely
engulfment. The latter could be investigated using the genetic screen I described, but
the former could be investigated by a candidate screen. As previously mentioned, in
apoptosis in the C. elegans embryo, CED-3 is required to convert the RNase DCR-1
to a DNase tDCR-1 to efficiently remove DNA from the dying cell [224]. To investigate
whether something similar could be occurring here, I tested a mutant of dcr-1. While the
research is still preliminary, there was a slight delay in corpse removal at 2h after the L4
to adult transition. The nuclease nuc-1, also a CED-3 target, has a small but significant
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corpse removal defect at 24h. Perhaps a nuc-1; dcr-1 double mutant would resemble
the ced-3 mutant animals and hint at the role of CED-3 in removing nuclear DNA from a
dead cell.
5.4. Concluding remarks
The studies described here suggest how linker cell death may be inhibited when
opposing cell survival signals are present. Additional studies are needed to determine
the exact molecular mechanism by which this inhibition occurs, but may provide much
needed clues to understanding how the HSF-1 switch is controlled in linker cell death.
These studies also provide clear mechanistic insight to how the linker cell corpse is
removed and degraded following cell death, which is controlled by two small GTPases,
RAB-35 and ARF-6, and their regulators. RAB-35 and ARF-6 have been previously
implicated in phagocytosis of pathogens, suggesting that the insights provided here
are well-conserved in many modes of phagocytosis. The finding that CED-3 is involved
in cell degradation and not cell death perhaps answers the question as to why many
mouse models of apoptotic knockout genes are viable: those genes are involved in the
degradation of cells that are dying by LCD. Investigating the role of LCD in mammalian
development is thus an urgent and exciting avenue of research in the near future.
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6. Materials and Methods
6.1. Reagents
6.1.1. C. elegans strains
C. elegans strains were raised at 20oC on nematode growth medium (NGM)
seeded with OP50 bacteria [240], unless otherwise indicated. Wild-type animals were
of the Bristol N2 strain. All strains have one of two mutations that generate a high
incidence of male progeny, him-8(e1489) IV or him-5(e1490) V. Mutants recovered
by EMS mutagenesis were outcrossed five times before use. Transgenic lines were
generated by injection of plasmid DNA mixes into the hermaphrodite gonad. Integrated
transgenic strains were generated with UV/trioxalen treatment [241] (Sigma, T6137) and
were outcrossed at least four times before imaging experiments. Most strains also had
one of three integrated linker cell markers qIs56[lag-2p::GFP] V, nsIs65[mig-24p::Venus]
X, or nsIs650[mig-24p::mKate2] X. Other alleles and transgenes are as follows:
LGI: chd-7(tm6138), chd-7(tm6139), chd-7(gk290), chd-7(gk306), rab-2(n3263),
ced-1(e1735), cep-1(gk138), dpy-5(e907)
LGII: rrf-3(pk1426), pqn-85(tm2334), pqn-85(tm2338), hsf-1(sy441),
cnt-1(gk899634), cnt-1(tm2313)
LGIII: zfp-1(ok554), rab-35(b1013), rab-35(tm2058), tbc-10(gk388086),
unc-119(ed3), ttr-52(tm2003), ttr-52(tm2078), F23H11.4(gk585084),
F23H11.4(gk165637), cnt-2(gm377), ced-9(n1950), ced-4(n1162)
LGIV: pqn-41(ns294), pqn-41(ns807), egl-20(n585), arf-6(tm1447), arf6(ns388), arf-6(ns751[D92N]), arf-6(ns752[D92N]), arf-6(ns753), arf-6(ns760[T44N]),
arf-6(ns761[T44N]), arf-6(ns762[T44N]), arf-6(ns763[I42M;P43T]), arf-6(ns765[Q67L]),
arf-6(ns771[Q67L]), arf-6(ns753), arf-6(ns764), arf-6(ns767), arf-6(ns769),
sand-1(or552), sand-1(ok1963), efa-6(ok3533), ced-10(n1993), ced-5(n1812),
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psr-1(ok714), psr-1(tm469), ced-3(n717), ced-3(n2452)
LGV: rde-1(ne219), egl-1(n1084n3082)
LGX: hpk-1(pk1393), sek-1(ag1), bar-1(ga80), rme-4(ns410), rme-4(ns412),
rme-4(b1001), rme-4(tm1865), tbc-13(ok1812), piki-1(ok2346), him-4(e1267),
git-1(ok1848), git-1(gk392605), gap-2(ok1001)
6.1.2. Transgenes generated or used in present study
Transgene

Constructs

nsIs387

UV/TMP integration of nsEx3148[mig-24p::rde-1-SL2mCherry + lag-2p::mCherry]

drSi13 II

hsf-1p::hsf-1-GFP::unc-54 3'UTR + Cbr-unc-119(+) single
copy insertion [189]

nsIs653

UV/TMP integration of nsEx5304[pLMK10[lin48p::mKate2-PH] (10 ng/ul)+ unc-119(+) (25 ng/ul) +
pBluescript (65 ng/ul)]

nsEx4770,-71,-88,-89
nsEx4361,4618,4668

rme-4 fosmid (WRM0615bE09) 10 ng/ul + lin-48p::mCh
(25 ng/ul) + pBluescript (65 ng/ul)

nsEx4721,-22,-16

pLMK11[lin-48p::rme-4a cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4559,-60,4748

pLMK12[mig-24p::rme-4a cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30[lag-2p::mCh] (25 ng/ul) +
pBluescript (35 ng/ul)

nsEx4669,-64,4742

pLMK13[lin-48p::rme-4b cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

pwIs268

rme-4 translational reporter, gift from B. Grant [207]

nsEx4658,-66,-91

pLMK14[lin-48p::rab-35 cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4654,-89,-90

pLMK15[mig-24p::rab-35 cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)

nsEx4813,-16,-47

pLMK16[mig-24p::rab-35(Q69L) cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)
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nsEx4799,4821,-31,
-29,20

pLMK17[mig-24p::rab-35(S24N) cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)

pwIs357

rab-35 translational reporter, gift from B. Grant [207]

nsEx4741,-49,-86,
4937,-81,-82

pLMK18[lin-48p::tbc-10 cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5703,-04,-05

pLMK19[lin-48p::tbc-10(R225A) cDNA-SL2-mCh](20 ng/ul)
+ odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsIs493

UV/TMP integration of sEx10170[rCes R06B10.5::GFP +
pCeh361]. Strain BC10170 from CGC.

nsIs595 V

UV/TMP integration of nsEx5132[pLMK20[lin-48p::YFPRAB-35 cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) +
pBluescript (65 ng/ul)]

nsIs713

UV/TMP integration of [pLMK21[lin-48p::mKate2-RAB-35
cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) + pBluescript (65
ng/ul)]

nsIs60

mig-24p::Venus + unc-119(+), a gift from M. Abraham

nsIs622 X

UV/TMP integration of nsEx4724[pLMK22[lin48p::mCherry-RAB-5 cDNA] (1 ng/ul)+ unc-119(+) (25 ng/
ul) + pBluescript (74 ng/ul)]

nsIs592 V

UV/TMP integration of nsEx5610[pLMK23[lin48p::mCherry-RAB-7 cDNA] (1 ng/ul)+ unc-119(+) (25 ng/
ul) + pBluescript (74 ng/ul)]

nsIs586 V

UV/TMP integration of nsEx5798[pLMK24[lin-48p::CTNS1-mKate2 cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) +
pBluescript (65 ng/ul)]

nsEx4717,-38,4848,
4564,-82,-83

pLMK25[lin-48p::arf-6 cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4657,-60,
4753,-85,-50

pLMK26[lin-48p::arf-6(D92N) cDNA-SL2-mCh](20 ng/ul) +
odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4825,-44,-45,
4815,-46,-49

pLMK27[mig-24p::arf-6 cDNA](20 ng/ul) + odr-1p::RFP(+)
(20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35 ng/ul)
pLMK28[mig-24p::arf-6(D92N) cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)
pLMK29[arf-6p::arf-6 genomic DNA-GFP-unc-54 3'UTR]
(10 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (65 ng/ul)

nsEx4787,-94, 4814
nsEx4595
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nsEx4602

pLMK30[arf-6p::arf-6(ns388) genomic DNA-GFP-unc-54
3'UTR] (10 ng/ul) + unc-119(+) (25 ng/ul) + pBluescript (65
ng/ul)

nsEx4953,-48, 5612,
5106,-10,-14,-59

pLMK31[lin-48p::arf-6(ΔG2) cDNA-SL2-mCh](20 ng/ul) +
odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4954,-67,5696

pLMK32[lin-48p::arf-6(ΔG2, D92N) cDNA-SL2-mCh](20
ng/ul) + odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5694,-95

pLMK33[lin-48p::cnt-1a cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4951,-52,-5692

pLMK34[mig-24p::cnt-1a cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)

nsEx5740,-42,-58

pLMK35[lin-48p::cnt-1a(R490A) cDNA-SL2-mCh](20 ng/ul)
+ odr-1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5741,-44,-60

pLMK36[lin-48p::cnt-1b cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx4938,-49,-50

pLMK37[mig-24p::cnt-1b cDNA](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (25 ng/ul) + pBluescript (35
ng/ul)

nsEx5757

pLMK38[cnt-1p::GFP] (10 ng/ul) + unc-119(+) (25 ng/ul) +
pBluescript (65 ng/ul)

nsEx5743,-56,-59

pLMK39[lin-48p::efa-6a cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5133,-51,-52

pLMK40[lin-48p::efa-6b cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5139,-47,-5140

pLMK41[lin-48p::efa-6c cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5134,-35,-40

pLMK42[lin-48p::efa-6d cDNA-SL2-mCh](20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

nsEx5100

pLMK43[efa-6p::GFP] (25 ng/ul) + unc-119(+) (25 ng/ul) +
pBluescript (50 ng/ul)

nsIs625

UV/TMP integration of nsEx5136[pLMK44[lin-48p::ARF-6YFP cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) + pBluescript
(65 ng/ul)]

nsIs636

UV/TMP integration of nsEx5130[pLMK45[lin-48p::ARF6(D92N)-YFP cDNA] (10 ng/ul)+ unc-119(+) (25 ng/ul) +
pBluescript (65 ng/ul)]
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nsEx4620,-31,-45,
-48,-49

pLMK64[lin-48p::MFGe8-GFP] (10 ng/ul) + unc-119(+) (25
ng/ul) + pBluescript (65 ng/ul), gift from Z. Zhou [151]

nsIs25

ced-3p::GFP, rol-6(+), gift from C. Maurer

nsEx4944,-5

pPG08[ced-3p::mCherry], a gift from P. Ghose (10 ng/ul) +
unc-119(+) (25 ng/ul) + pBluescript (65 ng/ul)]

bcIs109

ced-3p::ced-3-GFP, rol-6(+), gift from B. Conradt

nsEx5307

pLMK65[ced-4p::mKate2] (25 ng/ul) + unc-119(+) (25 ng/
ul) + pBluescript (50 ng/ul)]

nsEx5627,-8,-9,
nsEx5619,-20,-81

pLMK66[mig-24p::ced-4a cDNA] (20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pEB30 (20 ng/ul) + pBluescript (40
ng/ul)
pLMK67[lin-48p::ced-4a cDNA-SL2-mCh] (20 ng/ul) + odr1p::RFP(+) (20 ng/ul) + pBluescript (60 ng/ul)

6.1.3. Additional Plasmids generated or used in present study
Plasmid
Details
pLMK46
LexA-CNT-1A, Yeast two-hybrid (Y2H)
pLMK47
LexA-CNT-1B, Y2H
pLMK48
GAD-ARF-6, Y2H
pLMK49
GAD-ARF-6(D92N), Y2H
pLMK50
GAD-ARF-6(I42M,P43T), Y2H
pLMK51
LexA-ARF-6(T44N), Y2H
pLMK52
GAD-EFA-6A, Y2H
pLMK53
GAD-EFA-6B, Y2H
pLMK54
GAD-EFA-6C, Y2H
pLMK55
GAD-EFA-6D, Y2H
pLMK56
LexA-RAB-35(S24N), [GDP], Y2H
pLMK57
LexA-RAB-35(Q69L), [GTP], Y2H
pLMK58
GAD-CNT-1A, Y2H
pLMK59
GAD-CNT-1B, Y2H
pLMK60
GAD-RME-4A, Y2H
pLMK61
GAD-RME-4B, Y2H
pLMK62
arf-6[D92N] CRISPR targeting vector, pDD162 backbone
pLMK63
arf-6[T44N] CRISPR targeting vector, pDD162 backbone
pLMK64
arf-6[Q67L] CRISPR targeting vector, pDD162 backbone
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6.2. C. elegans methods
6.2.1. Forward genetic screen and artificial insemination
Young L4 hermaphrodites containing qIs56 [lag-2p::GFP] and him-5(e1490)
were mutagenized with 75 mM ethylmethanesulfonate (EMS, Sigma M0880) for 4h at
20oC. Animals were synchronized twice by bleaching, and male animals were enriched
by passing through a 40 μm cell strainer (BD Falcon) passively for 20 min [242]. Male
animals fit more readily through the mesh than hermaphrodites and were enriched to
~88%. Animals were then scored under a fluorescent dissecting microscope (Leica) for
presence of a linker cell by GFP 24h after the L4 to adult transition. GFP-expressing
animals were isolated away from hermaphrodites for 24h after that to accumulate
spermatids within the gonad. Mutant males were immobilized on a dried agar pad under
immersion oil, and spermatids removed with a needle containing SM buffer (50 mM
HEPES, pH 7, 50 mM NaCl, 25 mM KCl, 5 mM CaCl2, 1 mM MgSO4, 1 mg/ml BSA)
[206]. An N2 hermaphrodite with a single row of eggs was then immobilized on the
same dried agar pad and gently injected with the collected sperm through the vulva. We
typically tried to insert all spermatids into a single hermaphrodite. GFP+ heterozygous
progeny were collected, allowed to self fertilize, and linker cell persistence confirmed
under a dissecting microscope.
6.2.2. Gene identification
A combination of Hawaiian Snip-SNP mapping [243] and whole genome
sequencing [244] was used to identify rme-4(ns410), rme-4(ns412), and arf-6(ns388)
using output from galign [245]. rme-4 was confirmed by fosmid rescue using
WRM0615bE09, and arf-6 identification was confirmed by mutant cDNA expression and
CRISPR alleles.
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6.2.3. Linker cell survival and corpse persistence assays
Linker cell death was scored as previously described [87]. Briefly, unstarved
gravid hermaphrodites were bleached to isolate embryos, which were allowed to
hatch overnight in M9. Synchronized L1 animals were released on 9-cm NGM plates
seeded with OP50 or HT115 E. coli containing the RNAi construct of interest on IPTGRNAi plates. Male animals were isolated onto a new plate prior to the L4-to-adult
transition based on full retraction of the male tail tip with rays visible under the unshed
L4 cuticle. 2h or 24h later, these animals were mounted onto 2% agarose-water pads,
anaesthetized in 25 mM sodium azide, and examined on an Axioplan 2 fluorescence
microscope (Zeiss) with a 63x/1.4NA objective (Zeiss) and Nomarski optics. The linker
cell was identified by location, morphology, and fluorescence from reporter transgenes.
Cells were then scored as surviving, dead, or gone based on DIC morphology and
fluorescence. For heat shock experiments, animals were subjected to brief heat shock
4h prior to the L4 to adult transition [85].
6.2.4. Germline transformation and rescue experiments
Plasmid mixes containing the plasmid of interest, co-injection markers, and
pBluescript were injected into both gonads of young adult hermaphrodites [246].
Injected animals were singled onto NGM plates and allowed to grow for two
generations. Transformed animals based on co-injection markers were picked onto
single plates, and screened for stable inheritance of the extrachromosomal array. Only
lines from different P0 injected hermaphrodites were considered independent. For cellspecific rescue experiments, animals expressing mCherry in either the linker cell or the
U.l/rp cells were picked to a new plate at the early L4 stage, before linker cell death, to
avoid bias. Isolated animals were then staged based on tail morphology under a white
light microscope for appropriate linker cell scoring.
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6.2.5. RNAi assay
pL4440 RNAi plasmids containing coding sequence to genes of interest were
isolated from the Ahringer Library [247] (Source BioScience) and the coding sequence
was confirmed by sequencing. Additional targeting plasmids were generated by cloning
in the Y2H hit to the pL4440 vector. All plasmids were grown at 37oC in HT115 bacteria,
which have a plasmid containing an inducible promoter driving T7 RNA polymerase.
The bacteria were plated on NGM plates that had been supplemented with the antibiotic
carbomycin and IPTG. One day later, synchronized L1 animals were plated on the RNAi
plates and grown for two days before assaying for linker cell corpse persistence.
6.2.6. Apoptotic corpse assay
Strain and vectors used in assay were from the DUALHybrid Kit (Dualsystem
Biotech). Bait cDNA was cloned into the pLexA plasmid and prey cDNA was cloned into
pGAD vectors. These plasmids were cotransformed into NMY51 yeast strain using the
lithium acetate method described in the DualHybrid manual. Selection was performed
on SD plates lacking the amino acids leucine, tryptophan, and histidine.
6.3. Molecular biology methods
6.3.1. Yeast two-hybrid screen
Strain and vectors used in assay were from the DUALHybrid Kit (Dualsystem
Biotech). Bait cDNA was cloned into the pLexA plasmid and prey cDNA was cloned
into pGAD vectors, or a C. elegans cDNA library tagged to GAD was used as bait, in
the case of the screen. These plasmids were cotransformed into NMY51 yeast strain
using the lithium acetate method described in the DualHybrid manual. Selection was
performed on SD plates lacking at least the amino acids leucine, tryptophan, and
histidine, and occasionally adenine, where noted.
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6.3.2. Generation of arf-6 alleles using CRISPR-Cas9 genome editing
Alleles of arf-6 were generated using the co-CRISPR-based genome editing
method as previously described [248]. pDD162 was used as a vector backbone, and
the following sgRNA sequences were added for each individual CRISPR attempt
(D92N: 5’ CTAAAAACCTGTCTCTATCAG 3’; T44N: 5’ TCAGTGACCACAATGACGA
3’; Q67L 5’ CTTCAGGACGTCGGCGGAC 3’) to generate arf-6 targeting vectors. A
dpy-10 sgRNA-pDD162-based vector was also generated (5’ GCTACCATAGGCAC
CACGAG 3’). Single-stranded repair oligos were PAGE purified and ordered from
Sigma (D92N: 5’ aggaaaaaaaccaatttttccgcatttttcgcctaaaaacCTGTCTCTATtAGCaG
CGTCCATCACAAAAATGAGCGCCTGAGTTCCTGTGTAATAATGTC 3’; T44N: 5’
agCAATTCTGTACAAACTGAAGCTCGGGCAATCAGTGACCACAATTCCGAacGT
GGGCTTCAATGTGGAGACTGTCACGTATAAAAATATCAAATTCAACGT 3’; Q67L 5’
ggcctaaaaacccccaaaaaccccaatttttcttcagGACGTCGGCGGACttGACAAAATTCGAC
CCCTCTGGCGACATTATTACACAGGAACTCAGGCGCT 3’, dpy-10(cn64): 5’ CACTT
GAACTTCAATACGGCAAGATGAGAATGACTGGAAACCGTACCGCATGCGGTG
CCTATGGTAGCGGAGCTTCACATGGCTTCAGACCAACAGCCTAT 3’ [248]. N2
animals were injected with the following mix: 50 ng/μl dpy-10 sgRNA, 50 ng/μl arf-6
targeting vector, 20 ng/μl dpy-10(cn64) repair oligo, 20 ng/μl arf-6 repair oligo in 1x
injection buffer (20mM potassium phosphate, 3mM potassium citrate, 2% PEG, pH 7.5).
F1 animals with Dpy or Rol phenotypes were picked to individual plates, indicating
a CRISPR-based editing event had occurred. F1 animals were allowed to lay eggs,
and then genotyped for successful co-conversion of the arf-6 locus using PCR and
restriction enzyme screening or Cel1 digestion of heteroduplex DNA [249]. Non-Rol,
non-Dpy F2 animals were then singled and homozygosed for the arf-6 mutation.
6.3.3. Plasmid construction
Plasmids containing lin-48p, mig-24p, or transcriptional reporters were cloned
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using multi-piece one-step cloning into a modified pPD95.75 backbone lacking GFP.
For CRISPR-related vectors, plasmids were generated using a site-directed plasmid
mutagenesis protocol on pDD162 [250,251]. Yeast vectors were generated using
traditional cloning from either a pLexA-N-terminus vector or a pGAL4AD-N-terminus
vector (Dualsystems Biotech), and single amino acid change variants were generated
using QuikChange (Agilent).
6.4. Cell biology methods
6.4.1. Long-term imaging and movie generation
Early L4 male animals were imaged in a microfluidic device described in detail
in [201]. Animals were fed a constant flow of NA22 bacteria in S medium, supplemented
with kanamycin (50 ng/μl) to prevent bacterial overgrowth. Animals were immobilized
and imaged every 8 minutes for at least 20h. Mutant animals were typically imaged
for > 30h. Exposure time and light intensity was held constant across strains when the
same integrated transgene was imaged. Occasionally tail development was perturbed
by the flow of medium and repeated immobilization procedures, and these animals were
not included in subsequent analyses.
6.4.2. Deconvolution
Images were cropped to a region of interest surrounding the linker cell. We
measured the point-spread function (PSF) of our optical setup using red (580/605nm)
and green (505/515nm) fluorescent 200nm beads (ThermoFisher Scientific). Using
these PSFs, we deconvolved the cropped fluorescence z-stacks using the classic
maximum likelihood estimation (CMLE) algorithm with standard parameters (refractive
index of imaging medium: 1.338) in the Huygens Essential software (Huygens Essential
3.7.1) by Scientific Volume Imaging (SVI).
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6.4.3. Image Analysis
Image analysis was performed using custom-written Matlab R2016b (Mathworks)
scripts by Wolfgang Keil. To overlay imaging frames, I straightened each threedimensional image stack using a previously published algorithm [201,252] based on
a manually selected worm backbone in the DIC channel. To correct for small residual
animal movements during multi-channel acquisition, obvious landmarks visible in the
fluorescence channels, such as the cloaca, fluorescently labeled cells in the animal’s
tail, or vesicles within the U-cell descendants were then manually aligned to the DIC
channel in each frame. Time-lapse movies were generated by centering all straightened,
aligned images on the linker cell and cropping the entire movie to an appropriate size.
6.4.4. Protein structures
The co-crystal structure of human Arf6 with the ArfGAP ASAP3 (PDB 3LVQ)
was examined in Pymol (The PyMOL Molecular Graphics System, Version 1.2r3pre,
Schrödinger, LLC.) in silico mutagenesis for D92N and I42M;P43T was performed and
hydrophilic interactions tested within Pymol. Key residues in ASAP3 are conserved in
C. elegans CNT-1, and those for Arf6 are conserved in C. elegans ARF-6.
6.5. Data analysis
Statistical analysis was performed using GraphPad Prism. Statistical parameters
including mean ± standard error of the proportion, mean ± SEM, and N are reported in
the main text, figures and figure legends. Data is judged to be statistically significant
when p < 0.05 by Fisher’s exact test, χ2-test, or student’s t-test, where appropriate.
When comparing a transgenic line to the parental strain, a minimum of three
independent lines was scored. Approximately 100 animals from each of these lines were
examined for linker cell defects, and compared to the parental strain using a Fisher’s
exact test to determine significance. For ease of presentation, I pooled the lines from
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a given experiment and displayed them on the relevant figure using mean ± SEM (N =
3, 4, or 5 lines). If only a subset of the three lines showed significance using a Fisher’s
exact test, I indicated this on the figure and figure legend.
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7. Appendix: A list of mutants from the genetic screen.
Category explanations:
I. weakly surviving: Animals have a small but significant increase in the number of
surviving cells.
II. relatively healthy: There are no surviving cells by our strict classifications, but the
cells look pretty good overall. May represent a timing defect.
III. odd death: Cells are still dying, but are doing so in an atypical manner. May
represent an aberration in engulfment or degradation.
IV. delayed death: There is an increase in the number of cell corpses at 2h after the
adult molt, but not at 24h.
V. persistent corpse: There is an increase in the number of cell corpses at both 2h
and 24h after the molt.
FP. may represent a false positive.
Strain/Allele
Wild-type
(OS238)
ns414

I

26%

ns575
ns570
ns427
ns578
ns425
ns574

I
I
I
I
II
II

15%
13%
11%
10%
0
7%

ns417

ns389

ns428
ns426
ns587
ns485
ns580
ns573
ns579
ns594
ns435
ns483
ns581
ns416
ns544
ns431
ns432

Category

I

II

II
III
III
III
III
III
III
III
IV
IV
IV
IV
IV
IV
IV

% SLCs

% RH

%GFP 2h

%GFP 24h Notes

3%

6%

40% (157)

12% (100)

51% (35)

29% (14)

17%

5%

3%
0
2%
0
2%
0
9%
2%
0
0
9%
3%
12%
14%
4%

9%

17%
17%
0
14%
36%
25%

21%

23%
n.d.
4%
9%
2%
25%
n.d.
12%
6%
0
2%
3%
8%
8%
4%

130

63% (35)

60% (53)
64% (47)
39% (28)
52% (50)
80% (36)
52% (56)

83% (58)

50% (26)
71% (21)
46% (46)
45% (47)
59% (46)
70% (38)
47% (34)
41% (49)
78% (18)
74% (38)
84% (45)
73% (37)
65% (49)
61% (49)
56% (45)

33% (50)

Likely
on LGV

51% (53)

Likely
on LGIII

20% (55)
19% (58)
7% (30)
12% (51)
20% (45)
18% (39)

n.d.
11% (37)
10% (29)
20% (35)
5% (56)
9% (43)
n.d.
11% (44)
24% (59)
19% (37)
13% (38)
20% (25)
29% (42)
2% (45)
21% (43)

33% OD
24% OD
15% OD
16% OD
25% OD
18% OD
8% OD
29% OD
11% OD

ns545

IV

8%

6%

59% (49)

20% (13)

ns598

IV

7%

7%

74% (43)

12% (5)

ns388
ns412
ns576
ns410
ns430
ns434
ns421
ns429
ns586
ns568
ns577
ns584
ns411
ns566
ns419
ns418
ns433
ns415
ns575

V
V
V
V
V
V
FP
FP
FP
FP
FP
FP
FP
FP
FP
FP
FP
FP?
FP

2%
3%
12%
0%
0
4%
2%
2%
2%
2%
2%
0
0
8%
9%
8%
7%
0
7%

0
2%
21%
13%
9%
8%
14%
12%
11%
10%
13%
5%
0
9%
0
0
9%
n.d.
10%

95% (37)
88% (42)
85% (33)
95% (41)
61% (46)
52% (50)
55% (42)
52% (50)
40% (53)
56% (62)
53% (50)
57% (37)
38% (21)
41% (46)
40% (23)
33% (24)
38% (45)
38% (45)
54% (41)

60% (38)
57% (28)
30% (46)
67% (33)
30% (54)
27% (26)
13% (38)
11% (134)
16% (70)
12% (50)
9% (34)
17% (35)
21% (24)
8% (52)
6% (18)
40% (10)
10% (42)
11% (45)
21% (39)
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